WO2000027292A9 - Method and device for left atrial appendage occlusion - Google Patents
Method and device for left atrial appendage occlusionInfo
- Publication number
- WO2000027292A9 WO2000027292A9 PCT/US1999/026325 US9926325W WO0027292A9 WO 2000027292 A9 WO2000027292 A9 WO 2000027292A9 US 9926325 W US9926325 W US 9926325W WO 0027292 A9 WO0027292 A9 WO 0027292A9
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- occlusion device
- occluding
- section
- occlusion
- proximal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12136—Balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12122—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder within the heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
- A61B17/12172—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12181—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
- A61B17/12186—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices liquid materials adapted to be injected
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12181—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
- A61B17/12195—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices comprising a curable material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/122—Clamps or clips, e.g. for the umbilical cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00579—Barbed implements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00592—Elastic or resilient implements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00597—Implements comprising a membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00606—Implements H-shaped in cross-section, i.e. with occluders on both sides of the opening
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00615—Implements with an occluder on one side of the opening and holding means therefor on the other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00632—Occluding a cavity, i.e. closing a blind opening
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/08—Wound clamps or clips, i.e. not or only partly penetrating the tissue ; Devices for bringing together the edges of a wound
- A61B2017/081—Tissue approximator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B2017/1205—Introduction devices
Definitions
- Embolic stroke is the nation's third leading killer for adults, and is a major cause of disability. There are over 700,000 strokes per year in the United States alone. Of these, roughly 100,000 are hemoragic, and 600,000 are ischemic (either due to vessel narrowing or to embolism). The most common cause of embolic stroke emanating from the heart is thrombus formation due to atrial fibrillation. Approximately 80,000 strokes per year are attributable to atrial fibrillation. Atrial fibrillation is an arrhythmia of the heart that results in a rapid and chaotic heartbeat that produces lower cardiac output and irregular and turbulent blood flow in the vascular system. There are over five million people worldwide with atrial fibrillation, with about four hundred thousand new cases reported each year. Atrial fibrillation is associated with a 500 percent greater risk of stroke due to the condition. A patient with atrial fibrillation typically has a significantly decreased quality of life due, in part, to the fear of a stroke, and the pharmaceutical regimen necessary to reduce that risk.
- LAA left atrial appendage
- the LAA is a cavity which looks like a small finger or windsock and which is connected to the lateral wall of the left atrium between the mitral valve and the root of the left pulmonary vein.
- the LAA normally contracts with the rest of the left atrium during a normal heart cycle, thus keeping blood from becoming stagnant therein, but often fails to contract with any vigor in patients experiencing atrial fibrillation due to the discoordinate electrical signals associated with AF.
- thrombus formation is predisposed to form in the stagnant blood within the LAA.
- a method of occluding an atrial appendage comprises the steps of inhibiting changes in the volume of the appendage, and occluding the opening to the appendage.
- the inhibiting changes in the volume step preferably comprises introducing a bulking element into the appendage to resist compression of the appendage wall.
- the bulking element is an expandable element.
- the introducing an expandable bulking element step comprises deploying a self-expandable bulking element from a deployment catheter.
- the occluding step comprises positioning an occlusion element to enclose the bulking element within the appendage.
- a method of facilitating cell growth onto an atrial appendage occlusion device comprises the steps of positioning an occlusion device across the opening of the appendage, the occlusion device having a tissue attachment surface thereon.
- the method additionally comprises the step of resisting compression of the appendage at least during a tissue attachment period of time.
- the resisting step preferably comprises positioning a bulking structure within the appendage.
- an occlusion device for implantation within the left atrial appendage.
- the occlusion device comprises an occluding member, enlargeable from a reduced cross section to an enlarged cross section.
- the occlusion device may further comprise a stabilizing member, enlargeable from a reduced cross section to an enlarged cross section.
- the enlarged cross section of the stabilizing member may be less than the enlarged cross section of the occlusion member.
- the occlusion device preferably further comprises a hub between the occlusion member and the stabilizing member.
- the occlusion member comprises an expandable frame, which may be made from at least two spokes. Each spoke has a first end and a second end, and the first end is attached to the hub.
- the spokes are movable between an axial orientation to provide a low profile such as for transluminal implantation, and a radially enlarged orientation such as during implantation within the appendage to occlude the appendage.
- the stabilizing member comprises at least two elements which are movable from an axial orientation when the stabilizing member is in the reduced cross section to an inclined orientation when the stabilizing member is in the enlarged cross section.
- each element comprises a proximal section, a distal section, and a bend in- between the proximal and distal sections when the stabilizing member is in the enlarged cross section.
- the occlusion device further comprises at least one tissue attachment element such as a hook, spike or barb.
- an occlusion device for occluding a tubular body structure.
- the occlusion device comprises a body, having a longitudinal axis.
- An expandable occlusion member is provided at a first position on the axis, and a stabilizing member is provided at a second position on the axis.
- the occlusion member comprises a plurality of spokes which are hingeabiy attached to the body and movable between an axial orientation and an inclined orientation.
- the occlusion member further comprises a polymeric membrane carried by the spokes.
- the stabilizing member comprises at least three radially outwardly movable elements.
- a hinge is provided on the body between the occlusion member and the stabilizing member.
- One hinge construction comprises a helical coil.
- a method of making an occlusion device comprises the steps of providing a tube, having a first end, a second end, and a longitudinal axis. A plurality of axially extending slots are cut at a first position on the tube, to create a first plurality of longitudinal elements. A second plurality of axially extending slots are cut at a second position on the tube, to create a second plurality of longitudinal elements. The method further comprises the steps of providing a radially outwardly directed bias on at least one of the first and second plurality of elements. A polymeric membrane may be attached to at least one of the first and second plurality of elements.
- a hinge is provided on the tube in-between the first and second plurality of elements.
- a method of occluding an atrial appendage comprises the steps of introducing a stabilizing member into the appendage, for resisting compression of the appendage wall, and preventing rotation and axial migration of the implant, and positioning an occlusion member across the appendage.
- the introducing step preferably comprises introducing a radially expandable stabilizing member, and radially expanding the member within the appendage.
- the positioning step may comprise either positioning the occlusion member within the appendage, or positioning the occlusion member across an opening of the appendage.
- the introducing and positioning steps are accomplished by introducing a deployment catheter within the appendage and deploying the stabilizing member and occluding member from the catheter.
- the method further comprises the step of facilitating cell growth onto the occlusion member.
- FIG. 1 shows a perspective view of an embodiment having features of the invention with an occluding member and a retention member.
- FIG. 2 shows an end view of the apparatus of FIG. 1 in partial section.
- FIG. 3 shows a longitudinal cross-sectional view of the apparatus of FIGS. 1 and 2.
- FIG. 3A shows a perspective view of an apparatus having features of the invention.
- FIG. 3B shows an elevational view in partial section of the apparatus of FIG. 3A.
- FIG. 4 shows an elevational view of an apparatus having features of the invention in a deployed state within a body cavity.
- FIG. 5 shows an elevational view of an apparatus having features of the invention in a deployed state within a body cavity.
- FIG. 6 shows a perspective view of an apparatus for sealing off a body cavity having features of the invention.
- FIG. 7 shows an elevational view in partial section of an apparatus for sealing off a body cavity having features of the invention.
- FIG. 8 shows a transverse cross-sectional view of the apparatus of FIG. 7 taken along lines 8-8.
- FIG. 9 shows a schematic view of a patient's heart with a transeptal catheter deployed through the septum and a delivery catheter and apparatus for sealing off a body cavity disposed therein.
- FIG. 10 shows a schematic view of a patient's heart in partial section with a delivery catheter disposed within the opening of the LAA.
- FIG. 11 shows a magnified view of the delivery catheter distal end and the LAA of a patient of FIG. 10 with an apparatus for sealing off a body cavity partially deployed within the LAA.
- FIG. 12 shows the apparatus for sealing off a body cavity of FIG. 11 fully deployed within a LAA.
- FIG. 13 shows an elevational view of a device for occluding a body cavity having features of the invention.
- FIG. 14 shows a transverse cross sectional view of the device for occluding a body cavity of FIG. 13 taken along lines 14-14.
- FIG. 15 shows a device for occluding a body cavity having features of the invention deployed within a LAA.
- FIG. 16 shows a device for occluding a body cavity having features of the invention deployed within a LAA.
- FIG. 17 shows a LAA being occluded by a method having features of the invention.
- FIG. 18 shows a LAA occluded by method having features of the invention.
- FIG. 19 shows a LAA occluded by method having features of the invention.
- FIG. 20 is an elevational view of an apparatus for closing an interior body cavity of a patient in partial section having features of the invention.
- FIG. 21 is a schematic view of an apparatus for closing an interior body cavity of a patient in contact with tissue of a LAA.
- FIG. 22 is a schematic view of an apparatus for closing an interior body cavity of a patient in contact with tissue of a LAA.
- FIG. 23 shows a LAA which has been closed by a method having features of the invention.
- FIG. 24 is a perspective view of an occlusion device in accordance with the present invention.
- FIG. 25 is a side elevational view of the occlusion device shown in FIG. 24.
- FIG. 26 is a perspective view of an alternate embodiment of the present invention.
- FIG. 27 is a side elevational view of the embodiment shown in FIG. 26.
- FIG. 28 is a perspective view of a further embodiment of the present invention.
- FIG. 29 is a side elevational view of the embodiment of FIG. 28.
- FIG. 30 is a perspective view of a further occlusion device in accordance with the present invention.
- FIG. 31 is an end view taken along the line 31 -31 of FIG. 30.
- FIG. 32 is a schematic illustration of an inflatable balloon positioned within the occlusion device of FIG. 30.
- FIG. 33 is a schematic view of a pull string deployment embodiment of the occlusion device of FIG. 30.
- FIGS. 34A and 34B are side elevational schematic representations of partial and complete barrier layers on the occlusion device of FIG. 30.
- FIG. 35 is a side elevational schematic view of an alternate occlusion device in accordance with the present invention.
- FIG. 36 is a schematic view of a bonding layer mesh for use in forming a composite barrier membrane in accordance with the present invention.
- FIG. 37 is an exploded cross sectional view of the components of a composite barrier member in accordance with the present invention.
- FIG. 38 is a cross sectional view through a composite barrier formed from the components illustrated in FIG. 37.
- FIG. 39 is a top plan view of the composite barrier illustrated in FIG. 38.
- FIGS. 1 -3 show an embodiment of an occluding device 10 having features of the invention where an occluding member 11 is secured to a retention member 12 that is arranged to fix the occluding member in a desired position within a body passageway or cavity.
- the occluding member 11 generally has disc shape with an outer rim 13 around the perimeter of a frame structure 14 which supports a barrier 15.
- the outer rim 13 can be circular or polygonal, or any other shape that is suitable for conforming to the inside surface of a body cavity.
- a hub 16 can be located near the center of the occluding member 11 which serves to connect the retention member 12 to the occluding member, in addition to other functions.
- the outer rim 13 is typically made from a soft polymer material 17 which permits flexibility of the outer rim and facilitates sealing of the outer rim against the inside surface of a body cavity or passageway.
- the barrier 15 can be a thin mesh or film of material which serves to block the passage of material within an area surrounded by the outer rim 13.
- the barrier 15 can be secured to the outer rim 13 along its entire perimeter 18 in order to achieve a complete seal therebetween and can be molded into the outer rim 13 or bonded thereto by a suitable method such as gluing, welding, sewing or other suitable method.
- the outer rim 13 is at least partially supported by the frame structure 14 which connects the outer rim and the hub.
- the frame structure 14 can be made from one or more elements of high strength material such as stainless steel or MP35N, or may preferably be made from shape memory or pseudoelastic alloys such as NiTi, or any of a variety of known structural biodegradable materials (ejL polyglycolic acid, poly lactic acid, poly-L-lactic acid and derivatives or copolymers such as PLGA).
- the frame structure 14 is made from a material which can be self-expanding from a constrained configuration so that the occluding device 10 can be delivered to the deployment site in a low profile an flexible configuration which facilitates percutaneous delivery.
- a radial hoop 21 is contained within the soft polymer material 17 of the outer rim 13 and serves to maintain the annular shape of the outer rim and facilitate radial expansion of the outer rim from a constrained position or configuration.
- the radial hoop 21 may be isolated within the soft polymer material 17 of the outer rim 13, or may be connected to at least some of the elements 22 of the frame structure 14, in order to have stronger mechanical joint between the outer rim and the frame structure.
- the radial hoop 21 is shown in a substantially circular configuration, but may also be polygonal or otherwise suitably shared, and may have connections or joints spaced thereon to facilitate contraction or folding of the device for non-invasive delivery.
- the hub 16 may serve to house a rotational coupling 23 which is connected to the proximal end 24 of a tissue penetrating shaft 25 within the retention member.
- the rotational coupling 23 allows the transfer of torque to the tissue penetrating shaft 25 which preferably has a helically shaped extension or distal extremity 26 which is configured to screw into tissue and be mechanically fixed thereto.
- the rotational coupling 23 may also be configured to be longitudinally captured by the hub 16 but still be rotatably disposed therein.
- FIGS. 3A and 3B depict an alternative embodiment of an occluding device 10 having an occluding member 11 and a retention member 12.
- the retention member 12 has a shaft 28 and radially extending members 29 extending radially from a proximal end of the shaft.
- the radially extending members 29 serve to anchor the shaft 28 and the occluding member 11 by engaging the tissue surrounding the occluding device.
- the radially extending members are self-expanding from a constricted state and are made of a pseudo elastic alloy such as NiTi, or a high strength material such as stainless steel.
- the radially extending members 29 may be self- expanding from a constricted state, they may also be expanded by use of shape memory properties or a radial outward force as would be provided by an inflatable balloon or the like.
- the shaft 28 can be a single element or made of multiple elements, and can be made from the same materials as the radially extending members or different materials such as polymers or polymer composites.
- the radially extending members 29 have a proximaliy directed bias at their radial extremities 29A so that the members readily fold down and move easily in a distal direction during insertion of the occluding device 10, but spring outward and aggressively engage surrounding tissue upon movement in a proximal direction. This configuration of the radially extending members 29 allows easy insertion into a body cavity, but prevents egress of the device 10 in and outward or proximal direction.
- FIG. 4. depicts an occluding device 30 similar to that depicted in FIGS. 1-3 deployed within the left atrial appendage 31 of a patient.
- An outer rim or periphery 32 of the occluding device 30 is disposed adjacent the opening 33 of the left atrial appendage 31 in a position which allows for a substantial seal of the outer rim against the inside surface 34 of the LAA.
- a helically shaped distal extremity 35 of a tissue penetrating shaft 36 has been screwed into the wall tissue of the LAA and is mechanically secured thereto.
- a retention member 38 maintains the position of an occluding member 41 in a substantially perpendicular orientation with respect to a longitudinal axis of the LAA 42.
- FIG. 5 depicts an occluding device similar to that depicted in FIGS. 1 -4 deployed within a LAA 51 of a patient similar to what is shown in FIG. 4.
- the structure of an occluding member 52 of the embodiment as shown in FIG. 5 differs from that shown in FIG. 4 in that a barrier 53 and frame structure 54 of the embodiment of FIG. 5 protrudes proximaliy from a plane defined by an outer rim 55.
- This configuration may be useful for certain morphologies of patient's LAAs.
- One object of the invention is to create a smooth surface outside the body passageway or cavity in order to prevent turbulent flow or eddies of blood or other bodily fluid within the cavity or passageway.
- FIG. 6 shows an alternative embodiment of an occluding device 60 which has an occluding member 61, a frame structure 62, a barrier 63 and a retention member in the form of an expandable member 65 which has linked elements 66 that are preferably expandable from a constrained configuration.
- the expandable member 65 is generally cylindrical in shape and can have a series of circumferential linked elements 66 connected by links 68.
- the expandable member 65 depicts the expandable member 65 as a series of linked elements 66, those skilled in the art will realize that a similar effect can be achieved with a single wire in a helical configuration or a plurality of wires in a mesh or braided configuration, or any other suitable configuration that can be self-expanding from a constrained configuration or expanding with the application of heat or other form of energy or force.
- the expandable member 65 may be configured to be deployed by an outward radial force delivered from within the expandable member.
- An inflatable balloon or the like could be used to exert such a force.
- the expandable member is preferably secured to an outer rim 71 of the occluding member 61 but may also be secured to the frame structure 62 directly or indirectly.
- the expandable member 65 can be self-expanding from a constrained configuration as can the occluding member 61 and the frame structure 62 and outer rim 71 thereof.
- the frame structure 62, outer rim 71 and barrier 63 may have construction similar to that described above with regard to the similar elements of the embodiments depicted in FIGS. 1-5.
- the expandable member 65 as shown in FIG. 6 may also have a sheath 72 disposed around it so as to act as a shield between the expandable member and an inner surface of a patient's body cavity or passageway.
- the sheath 72 may facilitate the sealing function of the occluding member 61, but is primarily intended to prevent damage to either tissue on the inside surface of a body cavity or to the linked elements 66 of the expandable member.
- the sheath 72 may surround all or part of the expandable member 65 and may be made from a variety of suitable biocompatible materials such as Dacron®, Nylon, TFE, PTFE or ePTFE.
- the sheath 72 may be a weave, braid, film or have any other suitable configuration.
- Expandable member 65 may also be coated by dipping, spraying, or other suitable process with a friction reducing material such as Teflon®, or with an active compound such as heparin.
- FIG. 8 shows a transverse cross-sectional view of the embodiment of FIG. 7 taken at lines 8-8.
- the frame structure 62 has an axis or hub 73 disposed at approximately the center of the frame structure which serves to connect the various radial elements 74 of the frame structure.
- the hub 73 can have an independent structure that links the several elements 74 of the frame structure 62 or it may be merely the terminus of the various frame structure elements and have a solid composition. In either structure, the hub 73 preferably allows a constrained configuration of the occluding member 61 to facilitate percutaneous delivery of the occluding device 60.
- the hub 73 may also have a lumen disposed therein to allow passage of a guidewire of other guiding member. Preferably, the lumen would have a self sealing valve or gasket which prevents the passage of fluid or embolic material once the guidewire or guiding member is removed from the lumen.
- a schematic view of a patient's heart 80 in partial section shows a trans-septal catheter 81 having a proximal end 82 and a distal end 83.
- the distal end 83 of the trans-septal catheter 81 is disposed within a patient's heart 80 with the distal end 84 of a delivery catheter 85 extending from the distal end 83 of the trans- septal catheter.
- the distal end 83 of the trans-septal catheter 81 has breached the septum 86 of the patient's heart
- the proximal end 94 of the delivery catheter 85 extends proximaliy from the hemostasis valve 92 and has a Luer connector 95 attached to the proximal extremity thereof.
- the proximal end 96 of a plunger 97 extends from the Luer connector 95 of the delivery catheter.
- the proximal end 94 of the delivery catheter is arranged to allow rotational and axial movement of the plunger 97 while preventing blood or other bodily fluids from leaking between the delivery catheter 85 and the plunger 97.
- FIG. 10 a patient's heart 80 is shown in partial section with the distal end 84 of a delivery catheter 85 disposed within the LAA opening 87.
- FIG. 1 1 is a magnified view of the LAA 88 shown in FIG. 10 and the distal end of the delivery catheter 84, which is shown in partial section, contains a plunger 97 which is slideably disposed within an inner lumen 98 of the delivery catheter 85 and serves to apply axial force in a distal direction on the collapsed occluding member 101 disposed within the delivery catheter so as to force the occluding device 102 from the delivery catheter and deploy it.
- An occluding device 102 having an expandable member 103 and an occluding member 101 secured thereto is partially deployed and extending from the distal end of the delivery catheter 84 into the patient's LAA 88.
- the occluding device 102 can also be guided into the patient's LAA 88 by use of an appropriate guidewire or guiding member.
- FIG. 12 shows the occluding device 102 of FIG. 1 1 in a deployed state within the patient's LAA 88.
- An outer rim 104 of the occluding member 101 is in substantial sealing contact with the inside surface 105 of the LAA 88.
- the expandable member 103 has expanded so as to contact the inside surface 105 of the LAA and secure the occluding device 102 thereto and maintain the occluding member 101 in a substantially perpendicular orientation relative to a longitudinal axis 106 of the LAA 88.
- a barrier 107 is disposed within an area bounded by the outer rim 104 and is positioned to prevent the passage or embolic or other material to or from the LAA 88.
- the distal end 108 of the plunger 97 is extending from the distal end of the delivery catheter 84 after having pushed the occluding device 102 from the delivery catheter.
- an occluding device 1 10 having features of the invention is shown.
- the occluding device 110 has a delivery catheter 1 1 1 with a distal end 1 12, a detachment mechanism 1 13 disposed on the distal end of the delivery catheter and an occlusive body or inflatable member 1 14 detachably secured to the detachment mechanism.
- the inflatable member 1 14 has a proximal end 1 15 and a distal end 116 with the proximal end being attached to the detachment mechanism 113 and the distal end terminating at an end cap 1 17.
- the inflatable member 1 14 has a proximal end 1 15 and a distal end 116 with the proximal end being attached to the detachment mechanism 113 and the distal end terminating at an end cap 1 17.
- the 114 has an outside surface 1 18 that may contain a fibrosis inducing material such as Dacron® or other similar materials.
- the inflatable member 1 14 may be made from a fluid tight film of polymer material which can be either compliant or non-compliant.
- the inflatable member 114 is made from silicone, however, any suitable material such as polyethylene, pol ⁇ urethane or PET can be used.
- the detachment mechanism 113 can be activated by mechanical force or by delivery of thermal or optical energy by a suitable conduit. Alternatively, the inflatable member can be pushed into the LAA from the delivery catheter 1 1 1 by an elongate push member without the use of a detachment mechanism.
- the inflatable member 1 14 can be filled with a gas, fluid or gel which is injected under pressure through the delivery catheter 114 and into the inflatable member. Suitable fluids to inject would include saline and silicone.
- the inflatable member 114 may also be filled with a polymer material that can be hardened. Autologus fluid such as blood, or collagen may also be used.
- a fluid, gel or polymer used to fill the inflatable member may contain contrast agents such as gold, tantalum, bismuth, barium sulf ate or the like in order to improve visualization under fluoroscopy or x-ray imaging.
- FIG. 14 is a transverse cross-sectional view of the occluding device 110 of FIG. 13 taken along lines 14-14.
- An optional inner shaft 121 is shown disposed within the inflatable member 1 14, preferably in a concentric arrangement.
- the inner shaft 121 provides longitudinal axial support to the inflatable member 114 so as to maintain a longitudinal dimension of the inflatable member 1 14 when it is being inflated and deployed.
- the inner shaft 121 may be solid or contain one or more lumens that may or may not be in fluid communication with an inner lumen 122 of the inflatable member 1 14, and can be used for the passage of a guidewire or guiding member.
- FIG. 15 depicts an alternative embodiment of an occluding device 1 10 which consists of an inflatable member 114 similar to the inflatable member of FIG. 13, shown substantially deployed, within a patient's LAA 123.
- the inflatable member 1 14 has been at least partially filled with a fluid, gas or gel within the patient's LAA 123 such that the outside surface of the inflatable member 118 is in contact with at least part of the inside surface 124 of the LAA.
- the inflatable member 114 can have rib members 125 which can mechanically interlock with the trebeculae 126 of the inside surface of the LAA 124 or other surface irregularities of the inside surface of a patient's body cavity or passageway.
- the rib members 125 form a complete circumference of the inflatable member 114, but could also form a partial circumference, spiral configuration, or consist of random projections on the surface of the inflatable member
- the rib members 125 should extend radially about 1 to about 4 mm from the nominal surface of the inflatable member 1 14, and are preferably spaced about 3 to about 8 mm from each other.
- the rib members 125 may be made from any suitable polymer material, but are preferably made from the same material as the inflatable member, and are integrally molded thereon, or bonded thereto with a heat weld or adhesive bond suitable for bonding flexibly medical polymers.
- the inflatable member 1 14 is depicted with the distal end of the delivery catheter 1 12 and detachment mechanism 1 13 attached. As an alternative, or in addition to the polymer rib members 125 shown in FIG.
- barbs or hooks could be secured to the outside surface of the inflatable member 1 14 which are configured to engage the inside surface of a patient's LAA 124.
- barbs or hooks disposed on the outside surface of the inflatable member and configured to engage the tissue of the inside surface of a patient's LAA 124 would have a proximaliy directed bias at their radial extremity so that the barbs would fold down and move easily in a distal direction during insertion of the inflatable member 1 14, but would spring outward and aggressively engage the tissue of the body cavity upon movement in a proximal direction of the inflatable member.
- FIG. 16 depicts an occluding device 110 consisting of an inflatable member 1 14 which is shown deployed within a patient's LAA 123.
- the embodiment of the inflatable member 114 shown in FIG. 16 has an optional retention member 127 with a tissue penetrating shaft 128 which has a proximal 131 end and a distal end 132.
- a rotational coupling 133 is disposed at the proximal end 131 of the tissue penetrating shaft 128 and a helically shaped extremity 134 is disposed at the distal end of the shaft 132.
- the helically shaped distal extremity 134 is shown deployed within and mechanically engaging wall tissue 135 of the LAA so as to secure the inflatable member 114 and maintain its position within the LAA 123 of the patient.
- FIG. 17 shows an alternative embodiment of an occlusive member 140 consisting of a polymer mass 141 which has been injected or delivered into a patient's LAA 142.
- the distal end 143 of a delivery catheter 144 has a lumen 145 therein which extends to a proximal end of the delivery catheter which is in fluid communication with a source of pressurized polymer material.
- a source of pressurized polymer material 146 can be any type of pump or device capable of forcing a polymer fluid or gel into the proximal end of the delivery catheter with sufficient pressure to force the polymer fluid or gel out the distal end 143 of the delivery catheter 144 and into a patient's body cavity or passageway.
- the delivery catheter 144 may be positioned by the techniques discussed above, e.g., the Mullins trans- septal approach or any other suitable method. Once the distal end of the delivery catheter 143 is disposed within a desired portion of the patient's LAA 142, the polymer mass 141 may be injected to fill the cavity to the desired level.
- the LAA 142 can be completely or partially filled with the polymer mass 141 which can be formulated to harden over time, with heat or remain in a fluid or gel state.
- the distal end of the delivery catheter can optionally include an expandable member which is used to substantially seal the delivery catheter against the inside surface of the opening of the patient's body cavity during the delivery of polymer material.
- the expandable member can be an inflatable balloon or the like which are well known in the art.
- the inflatable member 114 may be deployed within the LAA 142 prior to injection of the polymer mass 141 and captured thereby so as to secure the polymer mass within the LAA.
- the polymer mass can be used to fill the patient's LAA and surround and secure a deployed device as shown in FIGS. 4 or 5 in the patient's LAA 142.
- the delivery catheter 144 may be withdrawn and the procedure terminated.
- the entire LAA 142 of a patient is filled with the polymer mass 141 as shown in FIG. 18 and hardens or gels to maintain its shape.
- the polymer mass 141 may retain a soft compressible form after setting or hardening so that it is at least partially compliant with the co ⁇ strictive pumping action of a heart and resistant to fatigue as a result thereof.
- a material used to form the polymer mass 141 may contain contrast agents such as gold, platinum, tantalum, bismuth or the like in order to better visualize the deployment of the polymer mass under fluoroscopic or x-ray imaging.
- FIG. 19 shows an occlusive coil 147 which has been deployed within an LAA 142.
- the occlusive coil 147 as shown has assumed a random configuration that is mechanically occluding the LAA 142 and which has induced clot and/or fibrosis formation
- FIG. 20 An apparatus for closing off a body cavity or passageway 150 is shown in FIG. 20 which has features of the present invention.
- the apparatus 150 has an elongate shaft 151 with an inner lumen 152 and a proximal end 153 and a distal end 154.
- Slideably disposed within the inner lumen 152 of the elongate shaft 151 are at least two elongate members 155 which have proximal ends 156 and distal ends 157 and have tissue attachment members 158 disposed on the distal ends.
- An optional distal anchor member 161 is also slideably disposed within the inner lumen 152 of the elongate shaft 151 and preferably has a distal end 162 terminating with a helical member 163.
- the proximal end 153 of the elongate shaft 151 has a proximal control module 164 which seals the inner lumen 152 of the elongate shaft 151 and allows rotation and translation of the proximal ends 156 of the elongate members 155 and the distal anchor member 161 while maintaining a seal between said members to prevent leakage of bodily fluids therefrom.
- the proximal control module 164 can optionally be configured to control advancement and retraction of the elongate members 155 and control activation of the tissue attachment members 158.
- FIG. 21 shows the apparatus for closing off a body cavity 150 of FIG. 20 with the distal ends of the elongate members 157 and the tissue attachment members 158 extending distally from the distal end of the elongate shaft 154.
- the distal ends of the elongate members 157 are angled or deflected from a longitudinal axis 165 of the elongate shaft 151 so as to engage tissue 166 of the opening 167 of the LAA 168 as shown.
- the elongate members 155 may be deflected by an abutment or angulation contained in the distal end of the elongate shaft 154, but are preferably preshaped in an angled configuration which manifests when the distal ends are freed of the constraint of the inner lumen 152 of the elongate shaft an allowed to assume their relaxed preshaped condition.
- the helical member 163 at the distal end 162 of the distal anchor member 161 is engaged with the wall tissue 171 of the LAA 168 so as to provide an optional anchor that can be used to move the elongate shaft 151 relative to the distal anchor member 161 and give greater control of the longitudinal axial movement of the elongate shaft relative to the LAA opening 167.
- the tissue attachment members 158 are shown attached to the annular edge 172 of the LAA opening 167.
- a closure member or retaining ring 173 may be advanced distally by applying axial force on an elongate push shaft 174 which draws the tissue attachment members 158 and the tissue attached thereto closer together as shown in FIG. 22.
- the closure member 173 is further advanced distally, the annular edge of the LAA 172 is drawn closed, and eventually, the annular edge of the LAA will be completely closed into a closed state with the closure member 173 surrounding and compressing the tissue of the annular edge as shown in FIG. 23.
- the tissue attachment members 158 may be detached, and the apparatus for closing off a body cavity 150 withdrawn.
- One alternative method can have the tissue attachment members 158 drawn together by retracting them proximaliy into the distal end 154 of the elongate shaft 151 as opposed to distally advancing the closure member 173 with the elongate push shaft 174.
- the annular edge of the LAA 172 can be drawn into a closed state within the distal end 154 of the elongate shaft 151 at which point the annular edge may be fixed in the closed state by a variety of methods including suturing, tissue welding, the application of a suitable biocompatible adhesive, surgical staples or the like.
- the occlusion device 10 comprises an occluding member 11 comprising a frame 14 and a barrier 15.
- the frame 14 comprises a plurality of radially outwardly extending spokes 17 each having a length within the range of from about 0.5 cm to about 2 cm from a hub 16.
- the spokes have an axial length of about 1.5 cm.
- anywhere within the range of from about 3 spokes to about 40 spokes may be utilized. In some embodiments, anywhere from about 12 to about 24 spokes are utilized, and, 18 spokes are utilized in one embodiment.
- the spokes are advanceable from a generally axially extending orientation such as to fit within a tubular introduction catheter to a radially inclined orientation as illustrated in FIG. 24 and FIG. 25 following deployment from the catheter.
- the spokes are biased radially outwardly such that the occlusion member expands to its enlarged, implantation cross-section under its own bias following deployment from the catheter.
- the occlusion member may be enlarged using any of a variety of enlargement structures such as an inflatable balloon.
- the spokes comprise a metal such as stainless steel, Nitinol, Elgiloy, or others which can be determined through routine experimentation by those of skill in the art. Wires having a circular or rectangular cross- section may be utilized depending upon the manufacturing technique. In one embodiment, rectangular cross section spokes are cut such as by known laser cutting techniques from tube stock, a portion of which forms the hub 16.
- the barrier 15 may comprise any of a variety of materials which facilitate cellular in-growth, such as ePTFE. The suitability of alternate materials for barrier 15 can be determined through routine experimentation by those of skill in the art.
- the barrier 15 may be provided on either one or both sides of the occlusion member.
- the barrier 15 comprises two layers, with one layer on each side of the frame 14. The two layers may be bonded to each other around the spokes 17 in any of a variety of ways, such as by heat bonding with or without an intermediate bonding layer such as polyethylene or FEP, adhesives, sutures, and other techniques which will be apparent to those of skill in the art in view of the disclosure herein.
- the barrier 15 preferably has a thickness of no more than about 0.003" and a porosity within the range of from about 5 ⁇ m to about 60 ⁇ m.
- the barrier 15 in one embodiment preferably is securely attached to the frame 14 and retains a sufficient porosity to facilitate cellular ingrowth and/or attachment.
- a bonding layer 254 preferably comprises a mesh or other porous structure having an open surface area within the range of from about 10% to about 90%.
- the open surface area of the mesh is within the range of from about 30% to about 60%.
- the opening or pore size of the bonding layer 254 is preferably within the range of from about 0.005 inches to about 0.050 inches, and, in one embodiment, is about 0.020 inches.
- the thickness of the bonding layer 254 can be varied widely, and is generally within the range of from about 0.0005 inches to about 0.005 inches. In a preferred embodiment, the bonding layer 254 has a thickness of about 0.001 to about 0.002 inches.
- One suitable polyethylene bonding mesh is available from Smith and Nephew, under the code,SN9.
- the bonding layer 254 is preferably placed adjacent one or both sides of a spoke or other frame element 14.
- the bonding layer 254 and frame 14 layers are then positioned in-between a first membrane 250 and a second membrane 252 to provide a composite membrane stack.
- the first membrane 250 and second 252 may comprise any of a variety of materials and thicknesses, depending upon the desired functional result.
- the membrane has a thickness within the range of from about 0.0005 inches to about 0.010 inches.
- the membranes 250 and 252 each have a thickness on the order of from about 0.001 inches to about 0.002 inches, and comprise porous ePTFE, having a porosity within the range of from about 10 microns to about 100 microns.
- the composite stack is heated to a temperature of from about 200° to about 300°, for about 1 minute to about 5 minutes under pressure to provide a finished composite membrane assembly with an embedded frame 14 as illustrated schematically in Figure 38.
- the final composite membrane has a thickness within the range of from about 0.001 inches to about 0.010 inches, and, preferably, is about 0.002 to about 0.003 inches in thickness.
- the thicknesses and process parameters of the foregoing may be varied considerably, depending upon the materials of the bonding layer 254 the first layer 250 and the second layer 252.
- the resulting finished composite membrane has a plurality of "unbonded" windows or areas 256 suitable for cellular attachment and/or ingrowth.
- the attachment areas 256 are bounded by the frame 14 struts, and the cross-hatch pattern formed by the bonding layer 254.
- the filaments of the bonding layer 254 are oriented in a ⁇ onparallel relationship with the struts of frame
- a regular window 256 pattern is produced.
- the foregoing procedure allows the bonding mesh to flow into the first and second membranes 250 and 252 and gives the composite membrane 15 greater strength (both tensile and tear strength) than the components without the bonding mesh.
- the composite allows uniform bonding while maintaining porosity of the membrane 15, to facilitate tissue attachment.
- the composite flexibility is preserved and the overall composite layer thickness can be minimized.
- the occlusion device 10 may be further provided with a bulking element or stabilizer 194.
- the stabilizer 194 may be spaced apart along an axis from the occluding member 11.
- a distal end 190 and a proximal end 192 are identified for reference.
- the designation proximal or distal is not intended to indicate any particular anatomical orientation or deployment orientation within the deployment catheter. As shown in FIGS. 24 and
- the stabilizer 194 is spaced distally apart from the occluding member 11.
- the occluding member 1 1 has an expanded diameter within the range of from about 1 cm to about 5 cm, and, in one embodiment, about 3 cm.
- the axial length of the occluding member 11 in an expanded, unstressed orientation from the distal end 192 to the proximal hub 16 is on the order of about 1 cm.
- the overall length of the occlusion device 10 from the distal end 192 to the proximal end 190 is within the range of from about 1.5 cm to about 4 cm and, in one embodiment, about 2.5 cm.
- the axial length of the stabilizer 194 between distal hub 191 and proximal hub 16 is within the range of from about 0.5 cm to about 2 cm, and, in one embodiment, about 1 cm.
- the expanded diameter of the stabilizer 194 is within the range of from about 0.5 cm to about 2.5 cm, and, in one embodiment, about 1.4 cm.
- the outside diameter of the distal hub 191 and proximal hub 16 is about 2.5 mm.
- the occlusion device 10 is provided with one or more retention structures for retaining the device in the left atrial appendage or other body lumen.
- a plurality of barbs or other anchors 195 are provided, for engaging adjacent tissue to retain the occlusion device 10 in its implanted position and to limit relative movement between the tissue and the occlusion device.
- the illustrated anchors are provided on one or more of the spokes 17, or other portion of frame 14.
- every spoke, every second spoke or every third spoke are provided with one or two anchors each.
- the illustrated anchor is in the form of a barb, for extending into tissue at or near the opening of the LAA.
- anchors 195 may also be provided on the stabilizer 194, such that it assists not only in orienting the occlusion device 10 and resisting compression of the LAA, but also in retaining the occlusion device 10 within the LAA.
- Any of a wide variety of structures may be utilized for anchor 195, either on the occluding member 1 1 or the stabilizer 194 or both, such as hooks, barbs, pins, sutures, adhesives and others which will be apparent to those of skill in the art in view of the disclosure herein.
- the occlusion device 10 is preferably positioned within a tubular anatomical structure to be occluded such as the left atrial appendage such that the occluding member 11 is positioned across or near the opening to the LAA and the stabilizer 194 is positioned within the LAA.
- the stabilizer 194 assists in the proper location and orientation of the occluding member 11, as well as resists compression of the LAA behind the occluding member 11.
- the present inventors have determined that following deployment of an occluding member 11 without a stabilizer 194 or other bulking structure to resist compression of the LAA, normal operation of the heart may cause compression and resulting volume changes in the LAA, thereby forcing fluid past the occluding member 11 and inhibiting or preventing a complete seal. Provision of a stabilizer 194 dimensioned to prevent the collapse or pumping of the LAA thus minimize leakage, and provision of the barbs facilitates endothelialization or other cell growth across the occluding member 1 1.
- the stabilizer 194 is preferably movable between a reduced cross sectional profile for transluminal advancement into the left atrial appendage, and an enlarged cross sectional orientation as illustrated to fill or to substantially fill a cross-section through the LAA.
- the stabilizing member may enlarge to a greater cross section than the anatomical cavity, to ensure a tight fit and minimize the likelihood of compression.
- One convenient construction includes a plurality of elements 196 which are radially outwardly expandable in response to axial compression of a distal hub 191 towards a proximal hub 16. Elements 196 each comprise a distal segment 198 and a proximal segment 202 connected by a bend 200.
- the elements 196 may be provided with a bias in the direction of the radially enlarged orientation as illustrated in FIG. 25, or may be radially expanded by applying an expansion force such as an axially compressive force between distal hub 191 and proximal hub 16 or a radial expansion force such as might be applied by an inflatable balloon.
- Elements 196 may conveniently be formed by laser cutting the same tube stock as utilized to construct the distal hub 191, proximal hub 16 and frame 14, as will be apparent to those of skill in the art in view of the disclosure herein.
- the various components of the occlusion device 10 may be separately fabricated or fabricated in subassemblies and secured together during manufacturing.
- a radiopaque dye or other visualizable media may be introduced on one side or the other of the occlusion device, to permit visualization of any escaped blood or other fluid past the occlusion device.
- the occlusion device may be provided with a capillary tube or aperture which permit introduction of a visualizable dye from the deployment catheter through the occlusion device and into the entrapped space on the distal side of the occlusion device.
- dye may be introduced into the entrapped space distal to the occlusion device such as by advancing a small gauge needle from the deployment catheter through the barrier 15 on the occlusion device, to introduce dye.
- FIG. 26-27 A further embodiment of the occlusion device 10 is illustrated in Figures 26-27.
- the occlusion device 10 comprises an occlusion member 11 and a stabilizing member 194 as in the previous embodiment.
- each of the distal segments 198 inclines radially outwardly in the proximal direction and terminates in a proximal end 204.
- the proximal end 204 may be provided with atraumatic configuration, for pressing against, but not penetrating, the wall of the left atrial appendage or other tubular body structure.
- Three or more distal segments 198 are preferably provided, and generally anywhere within the range of from about 6 to about 20 distal segments 198 may be used. In one embodiment, 9 distal segments 198 are provided.
- 3 of the distal segments 198 have an axial length of about 5 mm, and 6 of the distal segments 198 have an axial length of about 1 cm. Staggering the lengths of the proximal segments 198 may axially elongate the zone in the left atrial appendage against which the proximal ends 204 provide anchoring support for the occlusion device.
- the occlusion device 10 illustrated in Figures 26 and 27 is additionally provided with a hinge 206 to allow the longitudinal axis of the occlusion member 11 to be angularly oriented with respect to the longitudinal axis of the stabilizing member 194.
- the hinge 206 is a helical coil, although any of a variety of hinge structures can be utilized.
- the illustrated embodiment may be conveniently formed by laser cutting a helical slot through a section of the tube from which the principal structural components of the occlusion device 10 are formed.
- an annular band 208 connects the hinge 206 to a plurality of axially extending struts 210.
- Axial struts 210 are provided, spaced equilaterally around the circumference of the body.
- Axial struts 210 may be formed from a portion of the wall of the original tube stock, which portion is left in its original axial orientation following formation of the distal segments 198 such as by laser cutting from the tubular wall.
- the occlusion member 11 is provided with a proximal zone 212 on each of the spokes 17.
- Proximal zone 212 has an enhanced degree of flexibility, to accommodate the fit between the occlusion member 1 1 and the wall of the left atrial appendage.
- Proximal section 212 may be formed by reducing the cross sectional area of each of the spokes 17, or by increasing the length of each spoke by making a wave pattern as illustrated.
- Proximal point 214 may be contained within layers of the barrier 15, or may extend through or beyond the barrier 15 such as to engage adjacent tissue and assist in retaining the occlusion device 10 at the deployment site.
- the occlusion device 10 is provided with a proximal face 216 on the occlusion member 1 1 , instead of the open and proximaliy concave face on the embodiment of Figures 24 and 25.
- the proximal face 216 is formed by providing a proximal spoke 218 which connects at an apex 220 to each distal spoke 17.
- Proximal spokes 218 are each attached to a hub 222 at the proximal end 192 of the occlusion device 10.
- the barrier 15 may surround either the proximal face or the distal face or both on the occlusion member 1 1.
- a proximal spoke 218 connected by an apex 220 to a distal spoke 17 provides a greater radial force than a distal spoke 17 alone, which will provide an increased resistance to compression if the occlusion member 11 is positioned with the LAA.
- the occlusion device 10 comprises an occluding member but does not include a distinct stabilizing member as has been illustrated in connection with previous embodiments. Any of the embodiments previously disclosed herein may also be constructed using the occluding member only, and omitting the stabilizing member as will be apparent to those of skill in the art in view of the disclosure herein.
- the occluding device 10 comprises a proximal end 192, a distal end 190, and a longitudinal axis extending therebetween.
- a plurality of supports 228 extend between a proximal hub 222 and a distal hub 191. At least two or three supports 228 are provided, and preferably at least about six. In one embodiment, eight supports 228 are provided. However, the precise number of supports 228 can be modified, depending upon the desired physical properties of the occlusion device 10 as will be apparent to those of skill in the art in view of the disclosure herein, without departing from the present invention.
- Each support 228 comprises a proximal spoke portion 218, a distal spoke portion 217, and an apex 220 as has been discussed.
- each of the proximal spoke 218, distal spoke 17 and apex 220 may be a region on an integral support 228, such as a continuous rib or frame member which extends in a generally curved configuration as illustrated with a concavity facing towards the longitudinal axis of the occlusion device 10.
- no distinct point or hinge at apex 220 is necessarily provided as is disclosed in previous embodiments, which include a hinged connection between proximal spoke 218 and distal spoke 17.
- each support 228, is provided with one or two or more barbs 195.
- the occlusion device 10 is in its enlarged orientation, such as for occluding a left atrial appendage or other body cavity or lumen.
- each of the barbs 195 projects generally radially outwardly from the longitudinal axis, and are inclined in the proximal direction.
- the barbs 195 and corresponding support 228 are cut from a single ribbon, sheet or tube stock, the barb 195 will incline radially outwardly at approximately a tangent to the curve formed by the support 228.
- the occlusion device 10 illustrated in Figure 30 may be constructed in any of a variety of ways, as will become apparent to those of skill in the art in view of the disclosure herein.
- the occlusion device 10 is constructed by laser cutting a piece of tube stock to provide a plurality of axially extending slots in- between adjacent supports 228.
- each barb 195 can be laser cut from the corresponding support 228 or space in-between adjacent supports 228.
- the generally axially extending slots which separate adjacent supports 228 end a sufficient distance from each of the proximal end 192 and distal end 190 to leave a proximal hub 222 and a distal hub 191 to which each of the supports 228 will attach. In this manner, an integral cage structure may be formed.
- each of the components of the cage structure may be separately formed and attached together such as through soldering, heat bonding, adhesives, and other fastening techniques which are known in the art.
- a further method of manufacturing the occlusion device 10 is to laser cut a slot pattern on a flat sheet of appropriate material, such as a flexible metal or polymer, as has been discussed in connection with previous embodiments.
- the flat sheet may thereafter be rolled about an axis and opposing edges bonded together to form a tubular structure.
- the apex portion 220 which carries the barb 195 may be advanced from a low profile orientation in which each of the supports 228 extend generally parallel to the longitudinal axis, to an implanted orientation as illustrated, in which the apex 220 and the barb 195 are positioned radially outwardly from the longitudinal axis.
- the support 228 may be biased towards the enlarged orientation, or may be advanced to the enlarged orientation following positioning within the tubular anatomical structure, in any of a variety of manners.
- an inflatable balloon 230 is positioned within the occlusion device 10. Inflatable balloon 230 is connected by way of a removable coupling 232 to an inflation catheter 234.
- Inflation catheter 234 is provided with an inflation lumen for providing communication between an inflation media source 236 outside of the patient and the balloon 230. Following positioning within the target body lumen, the balloon 230 is inflated, thereby engaging barbs 195 with the surrounding tissue. The inflation catheter 234 is thereafter removed, by decoupling the removable coupling 232, and the inflation catheter 234 is thereafter removed. In an alternate embodiment, the supports 228 are radially enlarged such as through the use of a deployment catheter 238. Deployment catheter 238 comprises a lumen for movably receiving a deployment line 240. Deployment line 240 extends in a loop 244 formed by a slip knot 242.
- proximal retraction on the deployment line 240 will cause the distal hub 191 to be drawn towards the proximal hub 222, thereby radially enlarging the cross-sectional area of the occlusion device 10.
- the supports 228 will retain the radially enlarged orientation by elastic deformation, or may be retained in the enlarged orientation such as by securing the slip knot 242 immovably to the deployment line 240 at the fully radially enlarged orientation. This may be accomplished in any of a variety of ways, using additional knots, clips, adhesives, or other techniques known in the art.
- the occlusion device 10 may be provided with a barrier 15 such as a mesh or fabric as has been previously discussed.
- Barrier 15 may be provided on only one hemisphere such as proximal face 216, or may be carried by the entire occlusion device 10 from proximal end 192 to distal end 190.
- the barrier may be secured to the radially inwardly facing surface of the supports 228, as illustrated in Figure 34B, or may be provided on the radially outwardly facing surfaces of supports 228, or both.
- FIG. 35 A further embodiment of the occlusion device 10 is illustrated in Figure 35, in which the apex 220 is elongated in an axial direction to provide additional contact area between the occlusion device 10 and the wall of the tubular structure.
- one or two or three or more anchors 195 may be provided on each support 228, depending upon the desired clinical performance.
- the occlusion device 10 illustrated in Figure 35 may also be provided with any of a variety of other features discussed herein, such as a partial or complete barrier 15 covering.
- the occlusion device 10 illustrated in Figure 35 may be enlarged using any of the techniques disclosed elsewhere herein.
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002349667A CA2349667C (en) | 1998-11-06 | 1999-11-08 | Method and device for left atrial appendage occlusion |
EP99960236A EP1135068B1 (en) | 1998-11-06 | 1999-11-08 | Device for left atrial appendage occlusion |
AU17153/00A AU771096B2 (en) | 1998-11-06 | 1999-11-08 | Method and device for left atrial appendage occlusion |
JP2000580529A JP2003529384A (en) | 1998-11-06 | 1999-11-08 | Method and device for occluding left atrial appendage |
AT99960236T ATE512630T1 (en) | 1998-11-06 | 1999-11-08 | DEVICE FOR OCCLUSION OF THE LEFT ATRIUM APPENDIX |
HK02107141.1A HK1045452B (en) | 1998-11-06 | 2002-09-27 | Apparatus for preventing the pagssage of embolic material from a patient's left atrial appendage |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/187,200 US6152144A (en) | 1998-11-06 | 1998-11-06 | Method and device for left atrial appendage occlusion |
US09/187,200 | 1998-11-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000027292A1 WO2000027292A1 (en) | 2000-05-18 |
WO2000027292A9 true WO2000027292A9 (en) | 2000-09-28 |
Family
ID=22687995
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/026325 WO2000027292A1 (en) | 1998-11-06 | 1999-11-08 | Method and device for left atrial appendage occlusion |
Country Status (10)
Country | Link |
---|---|
US (1) | US6152144A (en) |
EP (1) | EP1135068B1 (en) |
JP (1) | JP2003529384A (en) |
CN (1) | CN100394895C (en) |
AT (1) | ATE512630T1 (en) |
AU (1) | AU771096B2 (en) |
CA (1) | CA2349667C (en) |
ES (1) | ES2367414T3 (en) |
HK (1) | HK1045452B (en) |
WO (1) | WO2000027292A1 (en) |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8690911B2 (en) | 2009-01-08 | 2014-04-08 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US8845711B2 (en) | 2007-10-19 | 2014-09-30 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US8870913B2 (en) | 2006-03-31 | 2014-10-28 | W.L. Gore & Associates, Inc. | Catch system with locking cap for patent foramen ovale (PFO) occluder |
US8926603B2 (en) | 2004-03-05 | 2015-01-06 | Hansen Medical, Inc. | System and method for denaturing and fixing collagenous tissue |
US8926647B2 (en) | 2002-03-20 | 2015-01-06 | Spiration, Inc. | Removable anchored lung volume reduction devices and methods |
US8974445B2 (en) | 2009-01-09 | 2015-03-10 | Recor Medical, Inc. | Methods and apparatus for treatment of cardiac valve insufficiency |
US8974484B2 (en) | 2001-09-11 | 2015-03-10 | Spiration, Inc. | Removable lung reduction devices, systems, and methods |
US8974527B2 (en) | 2003-08-08 | 2015-03-10 | Spiration, Inc. | Bronchoscopic repair of air leaks in a lung |
US9005242B2 (en) | 2007-04-05 | 2015-04-14 | W.L. Gore & Associates, Inc. | Septal closure device with centering mechanism |
US9017394B2 (en) | 1999-08-09 | 2015-04-28 | Cardiokinetix, Inc. | Retrievable cardiac devices |
US9198669B2 (en) | 2006-03-31 | 2015-12-01 | Spiration, Inc. | Articulable anchor |
US9216014B2 (en) | 2002-06-03 | 2015-12-22 | W.L. Gore & Associates, Inc. | Device with biological tissue scaffold for percutaneous closure of an intracardiac defect and methods thereof |
US9241695B2 (en) | 2002-03-25 | 2016-01-26 | W.L. Gore & Associates, Inc. | Patent foramen ovale (PFO) closure clips |
US9259267B2 (en) | 2005-09-06 | 2016-02-16 | W.L. Gore & Associates, Inc. | Devices and methods for treating cardiac tissue |
US9332992B2 (en) | 2004-08-05 | 2016-05-10 | Cardiokinetix, Inc. | Method for making a laminar ventricular partitioning device |
US9332993B2 (en) | 2004-08-05 | 2016-05-10 | Cardiokinetix, Inc. | Devices and methods for delivering an endocardial device |
US9351716B2 (en) | 2009-06-17 | 2016-05-31 | Coherex Medical, Inc. | Medical device and delivery system for modification of left atrial appendage and methods thereof |
US9545247B2 (en) | 2004-05-07 | 2017-01-17 | W.L. Gore & Associates, Inc. | Catching mechanisms for tubular septal occluder |
JP7082987B2 (en) | 2017-04-05 | 2022-06-09 | ナショナル・ユニバーシティ・オブ・アイルランド・ガルウェイ | Implantable medical device |
Families Citing this family (607)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6511468B1 (en) | 1997-10-17 | 2003-01-28 | Micro Therapeutics, Inc. | Device and method for controlling injection of liquid embolic composition |
US6312452B1 (en) | 1998-01-23 | 2001-11-06 | Innercool Therapies, Inc. | Selective organ cooling catheter with guidewire apparatus and temperature-monitoring device |
JP4187411B2 (en) * | 1998-01-30 | 2008-11-26 | セント ジュード メディカル エーティージー, インコーポレイテッド | Device for use in closing a septal defect |
US7491232B2 (en) | 1998-09-18 | 2009-02-17 | Aptus Endosystems, Inc. | Catheter-based fastener implantation apparatus and methods with implantation force resolution |
US6905494B2 (en) | 1998-03-31 | 2005-06-14 | Innercool Therapies, Inc. | Method and device for performing cooling- or cryo-therapies for, e.g., angioplasty with reduced restenosis or pulmonary vein cell necrosis to inhibit atrial fibrillation employing tissue protection |
US6602276B2 (en) | 1998-03-31 | 2003-08-05 | Innercool Therapies, Inc. | Method and device for performing cooling- or cryo-therapies for, e.g., angioplasty with reduced restenosis or pulmonary vein cell necrosis to inhibit atrial fibrillation |
US7291144B2 (en) | 1998-03-31 | 2007-11-06 | Innercool Therapies, Inc. | Method and device for performing cooling- or cryo-therapies for, e.g., angioplasty with reduced restenosis or pulmonary vein cell necrosis to inhibit atrial fibrillation |
US6685732B2 (en) | 1998-03-31 | 2004-02-03 | Innercool Therapies, Inc. | Method and device for performing cooling- or cryo-therapies for, e.g., angioplasty with reduced restenosis or pulmonary vein cell necrosis to inhibit atrial fibrillation employing microporous balloon |
US6179860B1 (en) * | 1998-08-19 | 2001-01-30 | Artemis Medical, Inc. | Target tissue localization device and method |
US6685627B2 (en) | 1998-10-09 | 2004-02-03 | Swaminathan Jayaraman | Modification of properties and geometry of heart tissue to influence heart function |
US8715156B2 (en) * | 1998-10-09 | 2014-05-06 | Swaminathan Jayaraman | Modification of properties and geometry of heart tissue to influence function |
US7128073B1 (en) | 1998-11-06 | 2006-10-31 | Ev3 Endovascular, Inc. | Method and device for left atrial appendage occlusion |
US7713282B2 (en) * | 1998-11-06 | 2010-05-11 | Atritech, Inc. | Detachable atrial appendage occlusion balloon |
US7044134B2 (en) | 1999-11-08 | 2006-05-16 | Ev3 Sunnyvale, Inc | Method of implanting a device in the left atrial appendage |
US6368338B1 (en) * | 1999-03-05 | 2002-04-09 | Board Of Regents, The University Of Texas | Occlusion method and apparatus |
US6488689B1 (en) | 1999-05-20 | 2002-12-03 | Aaron V. Kaplan | Methods and apparatus for transpericardial left atrial appendage closure |
US6375668B1 (en) * | 1999-06-02 | 2002-04-23 | Hanson S. Gifford | Devices and methods for treating vascular malformations |
US20020169473A1 (en) * | 1999-06-02 | 2002-11-14 | Concentric Medical, Inc. | Devices and methods for treating vascular malformations |
US6991643B2 (en) | 2000-12-20 | 2006-01-31 | Usgi Medical Inc. | Multi-barbed device for retaining tissue in apposition and methods of use |
WO2001000114A1 (en) | 1999-06-25 | 2001-01-04 | Vahid Saadat | Apparatus and methods for treating tissue |
US6626899B2 (en) | 1999-06-25 | 2003-09-30 | Nidus Medical, Llc | Apparatus and methods for treating tissue |
US20060229491A1 (en) * | 2002-08-01 | 2006-10-12 | Cardiokinetix, Inc. | Method for treating myocardial rupture |
US7303526B2 (en) * | 1999-08-09 | 2007-12-04 | Cardiokinetix, Inc. | Device for improving cardiac function |
US7674222B2 (en) | 1999-08-09 | 2010-03-09 | Cardiokinetix, Inc. | Cardiac device and methods of use thereof |
US8529430B2 (en) | 2002-08-01 | 2013-09-10 | Cardiokinetix, Inc. | Therapeutic methods and devices following myocardial infarction |
US7582051B2 (en) * | 2005-06-10 | 2009-09-01 | Cardiokinetix, Inc. | Peripheral seal for a ventricular partitioning device |
US10307147B2 (en) | 1999-08-09 | 2019-06-04 | Edwards Lifesciences Corporation | System for improving cardiac function by sealing a partitioning membrane within a ventricle |
US8388672B2 (en) | 1999-08-09 | 2013-03-05 | Cardiokinetix, Inc. | System for improving cardiac function by sealing a partitioning membrane within a ventricle |
US9694121B2 (en) * | 1999-08-09 | 2017-07-04 | Cardiokinetix, Inc. | Systems and methods for improving cardiac function |
US20030109770A1 (en) * | 1999-08-09 | 2003-06-12 | Sharkey Hugh R. | Device with a porous membrane for improving cardiac function |
US8257428B2 (en) * | 1999-08-09 | 2012-09-04 | Cardiokinetix, Inc. | System for improving cardiac function |
WO2001017435A1 (en) | 1999-09-07 | 2001-03-15 | Microvena Corporation | Retrievable septal defect closure device |
IL131863A0 (en) * | 1999-09-10 | 2001-03-19 | Bruckheimer Elchanan | Intravascular device and method using it |
US6231561B1 (en) * | 1999-09-20 | 2001-05-15 | Appriva Medical, Inc. | Method and apparatus for closing a body lumen |
US7615076B2 (en) | 1999-10-20 | 2009-11-10 | Anulex Technologies, Inc. | Method and apparatus for the treatment of the intervertebral disc annulus |
US7004970B2 (en) | 1999-10-20 | 2006-02-28 | Anulex Technologies, Inc. | Methods and devices for spinal disc annulus reconstruction and repair |
US20030153976A1 (en) * | 1999-10-20 | 2003-08-14 | Cauthen Joseph C. | Spinal disc annulus reconstruction method and spinal disc annulus stent |
US8632590B2 (en) | 1999-10-20 | 2014-01-21 | Anulex Technologies, Inc. | Apparatus and methods for the treatment of the intervertebral disc |
US6551303B1 (en) * | 1999-10-27 | 2003-04-22 | Atritech, Inc. | Barrier device for ostium of left atrial appendage |
US6689150B1 (en) * | 1999-10-27 | 2004-02-10 | Atritech, Inc. | Filter apparatus for ostium of left atrial appendage |
US6652555B1 (en) | 1999-10-27 | 2003-11-25 | Atritech, Inc. | Barrier device for covering the ostium of left atrial appendage |
US6702834B1 (en) * | 1999-12-30 | 2004-03-09 | Advanced Cardiovascular Systems, Inc. | Embolic protection devices |
US7842068B2 (en) | 2000-12-07 | 2010-11-30 | Integrated Vascular Systems, Inc. | Apparatus and methods for providing tactile feedback while delivering a closure device |
US6942674B2 (en) | 2000-01-05 | 2005-09-13 | Integrated Vascular Systems, Inc. | Apparatus and methods for delivering a closure device |
US6461364B1 (en) | 2000-01-05 | 2002-10-08 | Integrated Vascular Systems, Inc. | Vascular sheath with bioabsorbable puncture site closure apparatus and methods of use |
US9579091B2 (en) | 2000-01-05 | 2017-02-28 | Integrated Vascular Systems, Inc. | Closure system and methods of use |
US6391048B1 (en) | 2000-01-05 | 2002-05-21 | Integrated Vascular Systems, Inc. | Integrated vascular device with puncture site closure component and sealant and methods of use |
US8758400B2 (en) | 2000-01-05 | 2014-06-24 | Integrated Vascular Systems, Inc. | Closure system and methods of use |
US7056294B2 (en) * | 2000-04-13 | 2006-06-06 | Ev3 Sunnyvale, Inc | Method and apparatus for accessing the left atrial appendage |
WO2002000139A1 (en) * | 2000-06-23 | 2002-01-03 | Frantzen John J | Radially expandable aneurysm treatment stent |
AU2001273468B2 (en) | 2000-07-13 | 2005-05-26 | Recor Medical, Inc. | Energy application with inflatable annular lens |
EP2275175B1 (en) * | 2000-07-13 | 2016-08-24 | ReCor Medical, Inc. | Thermal treatment apparatus with ultrasonic energy application |
US6440152B1 (en) * | 2000-07-28 | 2002-08-27 | Microvena Corporation | Defect occluder release assembly and method |
US7762943B2 (en) | 2004-03-03 | 2010-07-27 | Cardiokinetix, Inc. | Inflatable ventricular partitioning device |
US7862500B2 (en) * | 2002-08-01 | 2011-01-04 | Cardiokinetix, Inc. | Multiple partitioning devices for heart treatment |
US7399271B2 (en) * | 2004-01-09 | 2008-07-15 | Cardiokinetix, Inc. | Ventricular partitioning device |
US8398537B2 (en) | 2005-06-10 | 2013-03-19 | Cardiokinetix, Inc. | Peripheral seal for a ventricular partitioning device |
US20060030881A1 (en) * | 2004-08-05 | 2006-02-09 | Cardiokinetix, Inc. | Ventricular partitioning device |
US10064696B2 (en) | 2000-08-09 | 2018-09-04 | Edwards Lifesciences Corporation | Devices and methods for delivering an endocardial device |
US9078660B2 (en) | 2000-08-09 | 2015-07-14 | Cardiokinetix, Inc. | Devices and methods for delivering an endocardial device |
CN1447669A (en) | 2000-08-18 | 2003-10-08 | 阿特里泰克公司 | Expandable implant devices for filtering blood flow from atrial appendages |
ATE503423T1 (en) | 2000-09-08 | 2011-04-15 | Abbott Vascular Inc | SURGICAL BRACE |
US7169164B2 (en) * | 2000-09-21 | 2007-01-30 | Atritech, Inc. | Apparatus for implanting devices in atrial appendages |
US6695833B1 (en) | 2000-09-27 | 2004-02-24 | Nellix, Inc. | Vascular stent-graft apparatus and forming method |
US6626918B1 (en) | 2000-10-06 | 2003-09-30 | Medical Technology Group | Apparatus and methods for positioning a vascular sheath |
US6589265B1 (en) | 2000-10-31 | 2003-07-08 | Endovascular Technologies, Inc. | Intrasaccular embolic device |
US6695867B2 (en) | 2002-02-21 | 2004-02-24 | Integrated Vascular Systems, Inc. | Plunger apparatus and methods for delivering a closure device |
US8690910B2 (en) | 2000-12-07 | 2014-04-08 | Integrated Vascular Systems, Inc. | Closure device and methods for making and using them |
US7905900B2 (en) * | 2003-01-30 | 2011-03-15 | Integrated Vascular Systems, Inc. | Clip applier and methods of use |
US6623510B2 (en) | 2000-12-07 | 2003-09-23 | Integrated Vascular Systems, Inc. | Closure device and methods for making and using them |
US7806904B2 (en) | 2000-12-07 | 2010-10-05 | Integrated Vascular Systems, Inc. | Closure device |
US7211101B2 (en) | 2000-12-07 | 2007-05-01 | Abbott Vascular Devices | Methods for manufacturing a clip and clip |
US6547804B2 (en) * | 2000-12-27 | 2003-04-15 | Scimed Life Systems, Inc. | Selectively permeable highly distensible occlusion balloon |
US20020133227A1 (en) * | 2001-02-28 | 2002-09-19 | Gregory Murphy | Ventricular restoration patch apparatus and method of use |
US6702763B2 (en) | 2001-02-28 | 2004-03-09 | Chase Medical, L.P. | Sizing apparatus and method for use during ventricular restoration |
JP2005508201A (en) * | 2001-03-08 | 2005-03-31 | アトリテック, インコーポレイテッド | Atrial filter implant |
US8961541B2 (en) | 2007-12-03 | 2015-02-24 | Cardio Vascular Technologies Inc. | Vascular closure devices, systems, and methods of use |
US8992567B1 (en) | 2001-04-24 | 2015-03-31 | Cardiovascular Technologies Inc. | Compressible, deformable, or deflectable tissue closure devices and method of manufacture |
US20080114394A1 (en) | 2001-04-24 | 2008-05-15 | Houser Russell A | Arteriotomy Closure Devices and Techniques |
US6855153B2 (en) * | 2001-05-01 | 2005-02-15 | Vahid Saadat | Embolic balloon |
US7338514B2 (en) | 2001-06-01 | 2008-03-04 | St. Jude Medical, Cardiology Division, Inc. | Closure devices, related delivery methods and tools, and related methods of use |
IES20010547A2 (en) | 2001-06-07 | 2002-12-11 | Christy Cummins | Surgical Staple |
WO2003007825A1 (en) * | 2001-07-19 | 2003-01-30 | Atritech, Inc. | Individually customized device for covering the ostium of left atrial appendage |
US7572288B2 (en) | 2001-07-20 | 2009-08-11 | Microvention, Inc. | Aneurysm treatment device and method of use |
US8252040B2 (en) | 2001-07-20 | 2012-08-28 | Microvention, Inc. | Aneurysm treatment device and method of use |
US8715312B2 (en) * | 2001-07-20 | 2014-05-06 | Microvention, Inc. | Aneurysm treatment device and method of use |
US20030028209A1 (en) | 2001-07-31 | 2003-02-06 | Clifford Teoh | Expandable body cavity liner device |
US7288105B2 (en) | 2001-08-01 | 2007-10-30 | Ev3 Endovascular, Inc. | Tissue opening occluder |
US7485088B2 (en) | 2001-09-05 | 2009-02-03 | Chase Medical L.P. | Method and device for percutaneous surgical ventricular repair |
US20040243170A1 (en) * | 2001-09-05 | 2004-12-02 | Mitta Suresh | Method and device for percutaneous surgical ventricular repair |
US20060052821A1 (en) | 2001-09-06 | 2006-03-09 | Ovalis, Inc. | Systems and methods for treating septal defects |
US6702835B2 (en) | 2001-09-07 | 2004-03-09 | Core Medical, Inc. | Needle apparatus for closing septal defects and methods for using such apparatus |
US20070129755A1 (en) * | 2005-12-05 | 2007-06-07 | Ovalis, Inc. | Clip-based systems and methods for treating septal defects |
US6776784B2 (en) | 2001-09-06 | 2004-08-17 | Core Medical, Inc. | Clip apparatus for closing septal defects and methods of use |
US6802851B2 (en) * | 2001-09-20 | 2004-10-12 | Gordia Neurovascular, Inc. | Stent aneurysm embolization method using collapsible member and embolic coils |
US6811560B2 (en) * | 2001-09-20 | 2004-11-02 | Cordis Neurovascular, Inc. | Stent aneurysm embolization method and device |
FR2832053B1 (en) * | 2001-11-13 | 2004-08-13 | Braun Medical | INTRALUMINAL OCCLUSIVE DEVICE WITH LOCALIZED MEMBRANE |
US20070073389A1 (en) | 2001-11-28 | 2007-03-29 | Aptus Endosystems, Inc. | Endovascular aneurysm devices, systems, and methods |
US8231639B2 (en) | 2001-11-28 | 2012-07-31 | Aptus Endosystems, Inc. | Systems and methods for attaching a prosthesis within a body lumen or hollow organ |
EP1448117B1 (en) | 2001-11-28 | 2013-05-22 | Aptus Endosystems, Inc. | Endovascular aneurysm repair system |
US20050177180A1 (en) | 2001-11-28 | 2005-08-11 | Aptus Endosystems, Inc. | Devices, systems, and methods for supporting tissue and/or structures within a hollow body organ |
US9320503B2 (en) | 2001-11-28 | 2016-04-26 | Medtronic Vascular, Inc. | Devices, system, and methods for guiding an operative tool into an interior body region |
US10098640B2 (en) | 2001-12-04 | 2018-10-16 | Atricure, Inc. | Left atrial appendage devices and methods |
WO2003053493A2 (en) | 2001-12-19 | 2003-07-03 | Nmt Medical, Inc. | Septal occluder and associated methods |
US7318833B2 (en) | 2001-12-19 | 2008-01-15 | Nmt Medical, Inc. | PFO closure device with flexible thrombogenic joint and improved dislodgement resistance |
US6764510B2 (en) | 2002-01-09 | 2004-07-20 | Myocor, Inc. | Devices and methods for heart valve treatment |
WO2003059152A2 (en) | 2002-01-14 | 2003-07-24 | Nmt Medical, Inc. | Patent foramen ovale (pfo) closure method and device |
CN1638703A (en) | 2002-01-25 | 2005-07-13 | 阿特里泰克公司 | Atrial appendage blood filtration systems |
US7695488B2 (en) * | 2002-03-27 | 2010-04-13 | Boston Scientific Scimed, Inc. | Expandable body cavity liner device |
US20060155303A1 (en) * | 2002-04-09 | 2006-07-13 | Andras Konya | Occlusion method and apparatus |
US7976564B2 (en) | 2002-05-06 | 2011-07-12 | St. Jude Medical, Cardiology Division, Inc. | PFO closure devices and related methods of use |
WO2003096881A2 (en) * | 2002-05-14 | 2003-11-27 | University Of Pittsburgh | Device and method of use for functional isolation of animal or human tissues |
US7338511B2 (en) * | 2002-05-24 | 2008-03-04 | Boston Scientific-Scimed, Inc. | Solid embolic material with variable expansion |
ATE417549T1 (en) | 2002-06-04 | 2009-01-15 | Abbott Vascular Inc | SURGICAL CLAMP AND APPLICATION DEVICE FOR VESSEL WOUND CLOSURE |
EP1538994A4 (en) | 2002-06-05 | 2008-05-07 | Nmt Medical Inc | Patent foramen ovale (pfo) closure device with radial and circumferential support |
US20040002630A1 (en) * | 2002-06-28 | 2004-01-01 | Wu Steven Zung-Hong | Suction device for surgical applications |
US20040082859A1 (en) | 2002-07-01 | 2004-04-29 | Alan Schaer | Method and apparatus employing ultrasound energy to treat body sphincters |
EP1539034B1 (en) * | 2002-08-01 | 2015-09-30 | Cardiokinetix, Inc. | A device for improving cardiac function |
JP4418366B2 (en) * | 2002-08-13 | 2010-02-17 | ウィルソン−クック・メディカル・インコーポレーテッド | ERCP catheter with removable handle for basket-compatible basket |
AU2003262938A1 (en) | 2002-08-27 | 2004-03-19 | Amir Belson | Embolic protection device |
US8758372B2 (en) * | 2002-08-29 | 2014-06-24 | St. Jude Medical, Cardiology Division, Inc. | Implantable devices for controlling the size and shape of an anatomical structure or lumen |
PT1531762E (en) | 2002-08-29 | 2010-07-21 | St Jude Medical Cardiology Div | Implantable devices for controlling the internal circumference of an anatomic orifice or lumen |
EP1542616B1 (en) | 2002-09-20 | 2015-04-22 | Endologix, Inc. | Stent-graft with positioning anchor |
WO2004026113A2 (en) * | 2002-09-23 | 2004-04-01 | Eva Corporation | Apparatus and method for reducing fluid loss during a surgical procedure |
US8303511B2 (en) | 2002-09-26 | 2012-11-06 | Pacesetter, Inc. | Implantable pressure transducer system optimized for reduced thrombosis effect |
US20040127855A1 (en) * | 2002-10-10 | 2004-07-01 | Nmt Medical, Inc. | Hemostasis valve |
WO2004037333A1 (en) | 2002-10-25 | 2004-05-06 | Nmt Medical, Inc. | Expandable sheath tubing |
US7108710B2 (en) | 2002-11-26 | 2006-09-19 | Abbott Laboratories | Multi-element biased suture clip |
WO2004052213A1 (en) * | 2002-12-09 | 2004-06-24 | Nmt Medical, Inc. | Septal closure devices |
US7857828B2 (en) | 2003-01-30 | 2010-12-28 | Integrated Vascular Systems, Inc. | Clip applier and methods of use |
US8202293B2 (en) | 2003-01-30 | 2012-06-19 | Integrated Vascular Systems, Inc. | Clip applier and methods of use |
US8398656B2 (en) | 2003-01-30 | 2013-03-19 | Integrated Vascular Systems, Inc. | Clip applier and methods of use |
US8758398B2 (en) | 2006-09-08 | 2014-06-24 | Integrated Vascular Systems, Inc. | Apparatus and method for delivering a closure element |
US8821534B2 (en) | 2010-12-06 | 2014-09-02 | Integrated Vascular Systems, Inc. | Clip applier having improved hemostasis and methods of use |
US8905937B2 (en) | 2009-02-26 | 2014-12-09 | Integrated Vascular Systems, Inc. | Methods and apparatus for locating a surface of a body lumen |
EP1596723A2 (en) | 2003-02-04 | 2005-11-23 | ev3 Sunnyvale, Inc. | Patent foramen ovale closure system |
WO2004071343A2 (en) | 2003-02-11 | 2004-08-26 | Cook, Inc. | Removable vena cava filter |
JP2006518648A (en) | 2003-02-20 | 2006-08-17 | プロリズム,インコーポレイテッド | Cardiac ablation device |
US7137991B2 (en) * | 2003-02-24 | 2006-11-21 | Scimed Life Systems, Inc. | Multi-wire embolic protection filtering device |
EP1605866B1 (en) | 2003-03-03 | 2016-07-06 | Syntach AG | Electrical conduction block implant device |
US7658747B2 (en) | 2003-03-12 | 2010-02-09 | Nmt Medical, Inc. | Medical device for manipulation of a medical implant |
US8372112B2 (en) | 2003-04-11 | 2013-02-12 | St. Jude Medical, Cardiology Division, Inc. | Closure devices, related delivery methods, and related methods of use |
US20040267306A1 (en) | 2003-04-11 | 2004-12-30 | Velocimed, L.L.C. | Closure devices, related delivery methods, and related methods of use |
US7175656B2 (en) * | 2003-04-18 | 2007-02-13 | Alexander Khairkhahan | Percutaneous transcatheter heart valve replacement |
US7597704B2 (en) | 2003-04-28 | 2009-10-06 | Atritech, Inc. | Left atrial appendage occlusion device with active expansion |
US7497857B2 (en) | 2003-04-29 | 2009-03-03 | Medtronic, Inc. | Endocardial dispersive electrode for use with a monopolar RF ablation pen |
AU2011213776B2 (en) * | 2003-05-12 | 2013-04-11 | Cardiokinetix, Inc | A system for improving cardiac function |
EP2191790A3 (en) | 2003-05-19 | 2012-10-17 | SeptRx, Inc. | Tissue distention device and related methods for therapeutic intervention |
US8480706B2 (en) | 2003-07-14 | 2013-07-09 | W.L. Gore & Associates, Inc. | Tubular patent foramen ovale (PFO) closure device with catch system |
EP1651116B1 (en) | 2003-07-14 | 2013-06-26 | W.L. Gore & Associates, Inc. | Tubular patent foramen ovale (pfo) closure device with catch system |
US9861346B2 (en) | 2003-07-14 | 2018-01-09 | W. L. Gore & Associates, Inc. | Patent foramen ovale (PFO) closure device with linearly elongating petals |
US9700450B2 (en) | 2003-07-28 | 2017-07-11 | Baronova, Inc. | Devices and methods for gastrointestinal stimulation |
US8048169B2 (en) * | 2003-07-28 | 2011-11-01 | Baronova, Inc. | Pyloric valve obstructing devices and methods |
US8821521B2 (en) | 2003-07-28 | 2014-09-02 | Baronova, Inc. | Gastro-intestinal device and method for treating addiction |
US9498366B2 (en) * | 2003-07-28 | 2016-11-22 | Baronova, Inc. | Devices and methods for pyloric anchoring |
US20090259236A2 (en) | 2003-07-28 | 2009-10-15 | Baronova, Inc. | Gastric retaining devices and methods |
US7735493B2 (en) * | 2003-08-15 | 2010-06-15 | Atritech, Inc. | System and method for delivering a left atrial appendage containment device |
CA2536368A1 (en) | 2003-08-19 | 2005-03-03 | Nmt Medical, Inc. | Expandable sheath tubing |
ATE375754T1 (en) * | 2003-09-12 | 2007-11-15 | Nmt Medical Inc | DEVICE FOR PREVENTING THROMB FORMATION IN THE LEFT ATRIAL APPENDIX |
WO2005027753A1 (en) * | 2003-09-19 | 2005-03-31 | St. Jude Medical, Inc. | Apparatus and methods for tissue gathering and securing |
WO2005034802A2 (en) * | 2003-10-09 | 2005-04-21 | Sentreheart, Inc. | Apparatus and method for the ligation of tissue |
US8292910B2 (en) | 2003-11-06 | 2012-10-23 | Pressure Products Medical Supplies, Inc. | Transseptal puncture apparatus |
US7666203B2 (en) | 2003-11-06 | 2010-02-23 | Nmt Medical, Inc. | Transseptal puncture apparatus |
US6976679B2 (en) * | 2003-11-07 | 2005-12-20 | The Boeing Company | Inter-fluid seal assembly and method therefor |
SE526861C2 (en) * | 2003-11-17 | 2005-11-15 | Syntach Ag | Tissue lesion creation device and a set of devices for the treatment of cardiac arrhythmia disorders |
EP3345577A1 (en) | 2003-12-04 | 2018-07-11 | Boston Scientific Scimed, Inc. | System for delivering a left atrail appendange containment device |
US20050273119A1 (en) | 2003-12-09 | 2005-12-08 | Nmt Medical, Inc. | Double spiral patent foramen ovale closure clamp |
US20050149068A1 (en) * | 2003-12-17 | 2005-07-07 | Mathew Williams | Left atrial appendage exclusion device |
US20110208233A1 (en) | 2004-01-22 | 2011-08-25 | Mcguckin Jr James F | Device for preventing clot migration from left atrial appendage |
US7704266B2 (en) * | 2004-01-22 | 2010-04-27 | Rex Medical, L.P. | Vein filter |
US20050192626A1 (en) | 2004-01-30 | 2005-09-01 | Nmt Medical, Inc. | Devices, systems, and methods for closure of cardiac openings |
WO2005074814A2 (en) | 2004-01-30 | 2005-08-18 | Nmt Medical, Inc. | Devices, systems, and methods for closure of cardiac openings |
US9398967B2 (en) | 2004-03-02 | 2016-07-26 | Syntach Ag | Electrical conduction block implant device |
EP1737349A1 (en) | 2004-03-03 | 2007-01-03 | NMT Medical, Inc. | Delivery/recovery system for septal occluder |
US20050234540A1 (en) * | 2004-03-12 | 2005-10-20 | Nmt Medical, Inc. | Dilatation systems and methods for left atrial appendage |
US8747453B2 (en) | 2008-02-18 | 2014-06-10 | Aga Medical Corporation | Stent/stent graft for reinforcement of vascular abnormalities and associated method |
US9039724B2 (en) | 2004-03-19 | 2015-05-26 | Aga Medical Corporation | Device for occluding vascular defects |
US8777974B2 (en) | 2004-03-19 | 2014-07-15 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects |
US8313505B2 (en) | 2004-03-19 | 2012-11-20 | Aga Medical Corporation | Device for occluding vascular defects |
US8398670B2 (en) | 2004-03-19 | 2013-03-19 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects and for occluding fluid flow through portions of the vasculature of the body |
US7686825B2 (en) | 2004-03-25 | 2010-03-30 | Hauser David L | Vascular filter device |
US7806846B2 (en) * | 2004-03-30 | 2010-10-05 | Nmt Medical, Inc. | Restoration of flow in LAA via tubular conduit |
US20050234543A1 (en) * | 2004-03-30 | 2005-10-20 | Nmt Medical, Inc. | Plug for use in left atrial appendage |
MXPA06006905A (en) * | 2004-04-08 | 2008-02-13 | Aga Medical Corp | Flange occlusion devices and methods. |
US20050267524A1 (en) | 2004-04-09 | 2005-12-01 | Nmt Medical, Inc. | Split ends closure device |
US8425539B2 (en) | 2004-04-12 | 2013-04-23 | Xlumena, Inc. | Luminal structure anchoring devices and methods |
AU2005235315B2 (en) | 2004-04-16 | 2010-09-09 | Cook, Inc. | Removable vena cava filter with anchoring feature for reduced trauma |
EP1737382B1 (en) | 2004-04-16 | 2011-03-30 | Cook Incorporated | Removable vena cava filter for reduced trauma in collapsed configuration |
US8043322B2 (en) | 2004-04-16 | 2011-10-25 | Cook Medical Technologies Llc | Removable vena cava filter having inwardly positioned anchoring hooks in collapsed configuration |
WO2005102213A1 (en) | 2004-04-16 | 2005-11-03 | Cook, Inc. | Removable vena cava filter having primary struts for enhanced retrieval and delivery |
US8361110B2 (en) | 2004-04-26 | 2013-01-29 | W.L. Gore & Associates, Inc. | Heart-shaped PFO closure device |
US8801746B1 (en) | 2004-05-04 | 2014-08-12 | Covidien Lp | System and method for delivering a left atrial appendage containment device |
US7842053B2 (en) | 2004-05-06 | 2010-11-30 | Nmt Medical, Inc. | Double coil occluder |
US8308760B2 (en) | 2004-05-06 | 2012-11-13 | W.L. Gore & Associates, Inc. | Delivery systems and methods for PFO closure device with two anchors |
US7704268B2 (en) | 2004-05-07 | 2010-04-27 | Nmt Medical, Inc. | Closure device with hinges |
US20050256532A1 (en) * | 2004-05-12 | 2005-11-17 | Asha Nayak | Cardiovascular defect patch device and method |
IES20040368A2 (en) | 2004-05-25 | 2005-11-30 | James E Coleman | Surgical stapler |
US8267985B2 (en) | 2005-05-25 | 2012-09-18 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
US7645285B2 (en) * | 2004-05-26 | 2010-01-12 | Idx Medical, Ltd | Apparatus and methods for occluding a hollow anatomical structure |
WO2006009729A2 (en) | 2004-06-18 | 2006-01-26 | Medtronic, Inc. | Methods and devices for occlusion of an atrial appendage |
US20060004388A1 (en) * | 2004-06-18 | 2006-01-05 | Ablatrics, Inc. | System for tissue cavity closure |
US8409219B2 (en) | 2004-06-18 | 2013-04-02 | Medtronic, Inc. | Method and system for placement of electrical lead inside heart |
CN100413471C (en) * | 2004-06-25 | 2008-08-27 | 深圳市先健科技股份有限公司 | Latching of left auricular appendix and conveyor thereof |
US7678081B2 (en) * | 2004-07-12 | 2010-03-16 | Pacesetter, Inc. | Methods and devices for transseptal access |
US8048145B2 (en) | 2004-07-22 | 2011-11-01 | Endologix, Inc. | Graft systems having filling structures supported by scaffolds and methods for their use |
CA2595809A1 (en) * | 2004-08-31 | 2006-03-09 | Cook Incorporated | Device for treating an aneurysm |
US7927346B2 (en) * | 2004-09-10 | 2011-04-19 | Stryker Corporation | Diversion device to increase cerebral blood flow |
US7753906B2 (en) * | 2004-09-14 | 2010-07-13 | Richard Esposito | Catheter having anchoring and stabilizing devices |
CA2581704C (en) * | 2004-09-17 | 2016-05-17 | Cordis Neurovascular, Inc. | Thin film metallic devices for plugging aneurysms or vessels |
CA2581677C (en) | 2004-09-24 | 2014-07-29 | Nmt Medical, Inc. | Occluder device double securement system for delivery/recovery of such occluder device |
EP1802252B1 (en) | 2004-09-27 | 2011-07-20 | Cook, Inc. | Removable vena cava filter |
US20070083168A1 (en) * | 2004-09-30 | 2007-04-12 | Whiting James S | Transmembrane access systems and methods |
US20060079787A1 (en) * | 2004-09-30 | 2006-04-13 | Whiting James S | Transmembrane access systems and methods |
US8029470B2 (en) * | 2004-09-30 | 2011-10-04 | Pacesetter, Inc. | Transmembrane access systems and methods |
US7374530B2 (en) | 2004-11-15 | 2008-05-20 | Benvenue Medical Inc. | Catheter-based tissue remodeling devices and methods |
US10064540B2 (en) | 2005-02-02 | 2018-09-04 | Intuitive Surgical Operations, Inc. | Visualization apparatus for transseptal access |
US7860555B2 (en) | 2005-02-02 | 2010-12-28 | Voyage Medical, Inc. | Tissue visualization and manipulation system |
US7918787B2 (en) | 2005-02-02 | 2011-04-05 | Voyage Medical, Inc. | Tissue visualization and manipulation systems |
US7860556B2 (en) | 2005-02-02 | 2010-12-28 | Voyage Medical, Inc. | Tissue imaging and extraction systems |
US8050746B2 (en) | 2005-02-02 | 2011-11-01 | Voyage Medical, Inc. | Tissue visualization device and method variations |
US11478152B2 (en) | 2005-02-02 | 2022-10-25 | Intuitive Surgical Operations, Inc. | Electrophysiology mapping and visualization system |
US8137333B2 (en) | 2005-10-25 | 2012-03-20 | Voyage Medical, Inc. | Delivery of biological compounds to ischemic and/or infarcted tissue |
US8078266B2 (en) | 2005-10-25 | 2011-12-13 | Voyage Medical, Inc. | Flow reduction hood systems |
US20080015569A1 (en) | 2005-02-02 | 2008-01-17 | Voyage Medical, Inc. | Methods and apparatus for treatment of atrial fibrillation |
US9510732B2 (en) * | 2005-10-25 | 2016-12-06 | Intuitive Surgical Operations, Inc. | Methods and apparatus for efficient purging |
US7930016B1 (en) | 2005-02-02 | 2011-04-19 | Voyage Medical, Inc. | Tissue closure system |
US8920434B2 (en) * | 2005-03-02 | 2014-12-30 | St. Jude Medical, Cardiology Division, Inc. | Remote body tissue engaging methods and apparatus |
US20060241687A1 (en) * | 2005-03-16 | 2006-10-26 | Glaser Erik N | Septal occluder with pivot arms and articulating joints |
US8277480B2 (en) | 2005-03-18 | 2012-10-02 | W.L. Gore & Associates, Inc. | Catch member for PFO occluder |
US8372113B2 (en) | 2005-03-24 | 2013-02-12 | W.L. Gore & Associates, Inc. | Curved arm intracardiac occluder |
US8864823B2 (en) * | 2005-03-25 | 2014-10-21 | StJude Medical, Cardiology Division, Inc. | Methods and apparatus for controlling the internal circumference of an anatomic orifice or lumen |
EP1861045B1 (en) * | 2005-03-25 | 2015-03-04 | St. Jude Medical, Cardiology Division, Inc. | Apparatus for controlling the internal circumference of an anatomic orifice or lumen |
US7918865B2 (en) | 2005-04-07 | 2011-04-05 | Sentreheart, Inc. | Apparatus and method for the ligation of tissue |
US8333777B2 (en) | 2005-04-22 | 2012-12-18 | Benvenue Medical, Inc. | Catheter-based tissue remodeling devices and methods |
CA2603499A1 (en) * | 2005-04-22 | 2006-11-02 | Rex Medical, L.P. | Closure device for left atrial appendage |
US8961586B2 (en) * | 2005-05-24 | 2015-02-24 | Inspiremd Ltd. | Bifurcated stent assemblies |
US10070977B2 (en) * | 2005-05-24 | 2018-09-11 | Inspire M.D. Ltd | Stent apparatuses for treatment via body lumens and methods of use |
US8043323B2 (en) | 2006-10-18 | 2011-10-25 | Inspiremd Ltd. | In vivo filter assembly |
CN101180006B (en) | 2005-05-25 | 2010-09-22 | 切斯纳特医药技术公司 | System and method for delivering and deploying and occluding device within a vessel |
US8273101B2 (en) | 2005-05-25 | 2012-09-25 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
ATE519434T1 (en) | 2005-06-02 | 2011-08-15 | Cordis Corp | MEDICAL DEVICE FOR USING A MECHANICAL CLOSURE DEVICE |
US8926633B2 (en) | 2005-06-24 | 2015-01-06 | Abbott Laboratories | Apparatus and method for delivering a closure element |
JP2007202614A (en) * | 2006-01-31 | 2007-08-16 | Kaneka Corp | Catheter |
US8313497B2 (en) | 2005-07-01 | 2012-11-20 | Abbott Laboratories | Clip applier and methods of use |
US8579936B2 (en) | 2005-07-05 | 2013-11-12 | ProMed, Inc. | Centering of delivery devices with respect to a septal defect |
EP1903985A4 (en) | 2005-07-07 | 2010-04-28 | Nellix Inc | Systems and methods for endovascular aneurysm treatment |
US20090012545A1 (en) * | 2005-07-14 | 2009-01-08 | Idx Medical, Ltd. | Apparatus and Methods for Occluding a Hallow Anatomical Structure |
US8157818B2 (en) | 2005-08-01 | 2012-04-17 | Ension, Inc. | Integrated medical apparatus for non-traumatic grasping, manipulating and closure of tissue |
WO2007022519A2 (en) | 2005-08-19 | 2007-02-22 | Chf Technologies, Inc. | Steerable heart implants for congestive heart failure |
US7824397B2 (en) * | 2005-08-19 | 2010-11-02 | Boston Scientific Scimed, Inc. | Occlusion apparatus |
US9456811B2 (en) | 2005-08-24 | 2016-10-04 | Abbott Vascular Inc. | Vascular closure methods and apparatuses |
US20070060895A1 (en) | 2005-08-24 | 2007-03-15 | Sibbitt Wilmer L Jr | Vascular closure methods and apparatuses |
US8920442B2 (en) | 2005-08-24 | 2014-12-30 | Abbott Vascular Inc. | Vascular opening edge eversion methods and apparatuses |
CA2621197A1 (en) | 2005-09-01 | 2007-03-08 | Cordis Corporation | Patent foramen ovale closure method |
US7846179B2 (en) | 2005-09-01 | 2010-12-07 | Ovalis, Inc. | Suture-based systems and methods for treating septal defects |
WO2007030433A2 (en) | 2005-09-06 | 2007-03-15 | Nmt Medical, Inc. | Removable intracardiac rf device |
US8057495B2 (en) * | 2005-09-13 | 2011-11-15 | Cook Medical Technologies Llc | Aneurysm occlusion device |
US20070060951A1 (en) * | 2005-09-15 | 2007-03-15 | Shannon Francis L | Atrial tissue fixation device |
US7972359B2 (en) | 2005-09-16 | 2011-07-05 | Atritech, Inc. | Intracardiac cage and method of delivering same |
US10143456B2 (en) * | 2005-10-07 | 2018-12-04 | Alex Javois | Left atrial appendage occlusion device |
US20070083232A1 (en) * | 2005-10-07 | 2007-04-12 | Innovasive, Inc. | Vascular closure device |
CN101466316B (en) | 2005-10-20 | 2012-06-27 | 阿普特斯内系统公司 | Devices systems and methods for prosthesis delivery and implantation including the use of a fastener tool |
US8221310B2 (en) | 2005-10-25 | 2012-07-17 | Voyage Medical, Inc. | Tissue visualization device and method variations |
US8852270B2 (en) * | 2007-11-15 | 2014-10-07 | Cardiosolutions, Inc. | Implant delivery system and method |
US9259317B2 (en) * | 2008-06-13 | 2016-02-16 | Cardiosolutions, Inc. | System and method for implanting a heart implant |
US8092525B2 (en) * | 2005-10-26 | 2012-01-10 | Cardiosolutions, Inc. | Heart valve implant |
US8449606B2 (en) * | 2005-10-26 | 2013-05-28 | Cardiosolutions, Inc. | Balloon mitral spacer |
US7785366B2 (en) * | 2005-10-26 | 2010-08-31 | Maurer Christopher W | Mitral spacer |
US8216302B2 (en) * | 2005-10-26 | 2012-07-10 | Cardiosolutions, Inc. | Implant delivery and deployment system and method |
US8778017B2 (en) * | 2005-10-26 | 2014-07-15 | Cardiosolutions, Inc. | Safety for mitral valve implant |
US7632308B2 (en) | 2005-11-23 | 2009-12-15 | Didier Loulmet | Methods, devices, and kits for treating mitral valve prolapse |
US20070135826A1 (en) | 2005-12-01 | 2007-06-14 | Steve Zaver | Method and apparatus for delivering an implant without bias to a left atrial appendage |
US8052715B2 (en) * | 2005-12-01 | 2011-11-08 | Atritech, Inc. | Method and apparatus for recapturing an implant from the left atrial appendage |
US9034006B2 (en) * | 2005-12-01 | 2015-05-19 | Atritech, Inc. | Method and apparatus for retrieving an embolized implant |
US8142470B2 (en) | 2005-12-01 | 2012-03-27 | Atritech, Inc. | Method for accessing the left atrial appendage with a balloon-tipped transeptal sheath |
US20070167981A1 (en) | 2005-12-22 | 2007-07-19 | Nmt Medical, Inc. | Catch members for occluder devices |
CN100444811C (en) * | 2006-01-16 | 2008-12-24 | 孔祥清 | Automatically positioned left auricle block instrument |
US20070173798A1 (en) * | 2006-01-23 | 2007-07-26 | Adams Mark L | Minimally invasive methods for thermal treatment |
US8551135B2 (en) | 2006-03-31 | 2013-10-08 | W.L. Gore & Associates, Inc. | Screw catch mechanism for PFO occluder and method of use |
US8814947B2 (en) | 2006-03-31 | 2014-08-26 | W.L. Gore & Associates, Inc. | Deformable flap catch mechanism for occluder device |
US20070244494A1 (en) * | 2006-04-18 | 2007-10-18 | Downing Stephen W | Methods and devices for treating atrial septal defects |
US8808310B2 (en) | 2006-04-20 | 2014-08-19 | Integrated Vascular Systems, Inc. | Resettable clip applier and reset tools |
WO2007131110A2 (en) | 2006-05-03 | 2007-11-15 | Raptor Ridge, Llc | Systems and methods of tissue closure |
EP2021846B1 (en) | 2006-05-19 | 2017-05-03 | Koninklijke Philips N.V. | Ablation device with optimized input power profile |
US9055906B2 (en) | 2006-06-14 | 2015-06-16 | Intuitive Surgical Operations, Inc. | In-vivo visualization systems |
US8556930B2 (en) | 2006-06-28 | 2013-10-15 | Abbott Laboratories | Vessel closure device |
USD611144S1 (en) | 2006-06-28 | 2010-03-02 | Abbott Laboratories | Apparatus for delivering a closure element |
JP2010502313A (en) | 2006-09-01 | 2010-01-28 | ボエッジ メディカル, インコーポレイテッド | Method and apparatus for the treatment of atrial fibrillation |
US20080097476A1 (en) | 2006-09-01 | 2008-04-24 | Voyage Medical, Inc. | Precision control systems for tissue visualization and manipulation assemblies |
US10004388B2 (en) | 2006-09-01 | 2018-06-26 | Intuitive Surgical Operations, Inc. | Coronary sinus cannulation |
CA2664686C (en) * | 2006-09-29 | 2015-06-02 | Cordis Corporation | Single disc intraluminal fixation patent foramen ovale closure device |
CA2887189C (en) * | 2006-10-18 | 2018-05-01 | Inspiremd Ltd. | Knitted stent jackets |
CN102670330B (en) * | 2006-10-18 | 2015-06-24 | 印斯拜尔Md有限公司 | Filter assemblies |
US20100324664A1 (en) * | 2006-10-18 | 2010-12-23 | Asher Holzer | Bifurcated Stent Assemblies |
US10335131B2 (en) | 2006-10-23 | 2019-07-02 | Intuitive Surgical Operations, Inc. | Methods for preventing tissue migration |
EP1982655B2 (en) * | 2007-04-16 | 2022-12-07 | Occlutech Holding AG | Occluder to seal an atrial appendage and method of manufacture thereof |
DE602007009915D1 (en) * | 2006-11-20 | 2010-12-02 | Septrx Inc | Device for preventing unwanted flow of emboli from the veins into the arteries |
CN101578078B (en) | 2006-11-22 | 2013-01-02 | 印斯拜尔Md有限公司 | Optimized stent jacket |
EP2129425B1 (en) | 2006-11-29 | 2023-12-27 | Emboline, INC. | Embolic protection device |
US20080178890A1 (en) * | 2006-12-18 | 2008-07-31 | Vacare Tehnologies, Llc | Method and apparatus for transcervical reversible cornual sterilization |
US20080183036A1 (en) | 2006-12-18 | 2008-07-31 | Voyage Medical, Inc. | Systems and methods for unobstructed visualization and ablation |
US9226648B2 (en) | 2006-12-21 | 2016-01-05 | Intuitive Surgical Operations, Inc. | Off-axis visualization systems |
US8131350B2 (en) | 2006-12-21 | 2012-03-06 | Voyage Medical, Inc. | Stabilization of visualization catheters |
CA2674485A1 (en) * | 2007-01-03 | 2008-07-17 | Mitralsolutions, Inc. | Implantable devices for controlling the size and shape of an anatomical structure or lumen |
US8647367B2 (en) * | 2007-01-23 | 2014-02-11 | Cvdevices, Llc | Devices, systems, and methods for percutaneous trans-septal left atrial appendage occlusion |
US8480708B2 (en) * | 2007-01-23 | 2013-07-09 | Cvdevices, Llc | Devices, systems, and methods for percutaneous trans-septal left atrial appendage occlusion |
US11166703B2 (en) | 2007-01-23 | 2021-11-09 | Cvdevices, Llc | Devices, systems, and methods for atrial appendage occlusion using light cure |
WO2008097999A2 (en) * | 2007-02-05 | 2008-08-14 | Mitralsolutions, Inc. | Minimally invasive system for delivering and securing an annular implant |
BRPI0809253A2 (en) * | 2007-03-20 | 2014-09-23 | Minvasys | DEVICES AND METHODS FOR EMBOLIC PROTECTIVE STENT INSTALLATION. |
JP4594953B2 (en) * | 2007-03-28 | 2010-12-08 | オリンパスメディカルシステムズ株式会社 | Endoscopic treatment tool and sewing device |
EP2929842B1 (en) | 2007-03-30 | 2019-06-12 | Sentreheart, Inc. | Devices and sytems for closing the left atrial appendage |
US20080243141A1 (en) | 2007-04-02 | 2008-10-02 | Salvatore Privitera | Surgical instrument with separate tool head and method of use |
US9138562B2 (en) | 2007-04-18 | 2015-09-22 | W.L. Gore & Associates, Inc. | Flexible catheter system |
EP2148608A4 (en) | 2007-04-27 | 2010-04-28 | Voyage Medical Inc | Complex shape steerable tissue visualization and manipulation catheter |
US8657805B2 (en) | 2007-05-08 | 2014-02-25 | Intuitive Surgical Operations, Inc. | Complex shape steerable tissue visualization and manipulation catheter |
US8709008B2 (en) | 2007-05-11 | 2014-04-29 | Intuitive Surgical Operations, Inc. | Visual electrode ablation systems |
US8480730B2 (en) * | 2007-05-14 | 2013-07-09 | Cardiosolutions, Inc. | Solid construct mitral spacer |
JP2010527742A (en) * | 2007-05-31 | 2010-08-19 | レックス メディカル リミテッド パートナーシップ | Left atrial appendage closure device |
JP2010532180A (en) * | 2007-05-31 | 2010-10-07 | レックス メディカル リミテッド パートナーシップ | Fallopian tube occlusion device |
US20110022149A1 (en) | 2007-06-04 | 2011-01-27 | Cox Brian J | Methods and devices for treatment of vascular defects |
CA2704920C (en) | 2007-06-25 | 2016-08-16 | Microvention, Inc. | Self-expanding prosthesis |
US8226681B2 (en) | 2007-06-25 | 2012-07-24 | Abbott Laboratories | Methods, devices, and apparatus for managing access through tissue |
US8235985B2 (en) | 2007-08-31 | 2012-08-07 | Voyage Medical, Inc. | Visualization and ablation system variations |
EP2185084A4 (en) | 2007-09-07 | 2017-08-09 | Baronova, Inc. | Device for intermittently obstructing a gastric opening and method of use |
WO2009039191A2 (en) | 2007-09-20 | 2009-03-26 | Sentreheart, Inc. | Devices and methods for remote suture management |
US8500759B2 (en) | 2007-09-26 | 2013-08-06 | Ethicon, Inc. | Hernia mesh support device |
JP2010540160A (en) | 2007-10-05 | 2010-12-24 | マッケ カーディオバスキュラー,エルエルシー | Apparatus and method for minimally invasive surgical procedures |
US20090112311A1 (en) * | 2007-10-19 | 2009-04-30 | Coherex Medical, Inc. | Medical device for percutaneous paravalvular leak and related systems and methods |
US8597347B2 (en) * | 2007-11-15 | 2013-12-03 | Cardiosolutions, Inc. | Heart regurgitation method and apparatus |
US8893947B2 (en) | 2007-12-17 | 2014-11-25 | Abbott Laboratories | Clip applier and methods of use |
US20090157101A1 (en) | 2007-12-17 | 2009-06-18 | Abbott Laboratories | Tissue closure system and methods of use |
US7841502B2 (en) | 2007-12-18 | 2010-11-30 | Abbott Laboratories | Modular clip applier |
US8246672B2 (en) | 2007-12-27 | 2012-08-21 | Cook Medical Technologies Llc | Endovascular graft with separately positionable and removable frame units |
US20090171386A1 (en) | 2007-12-28 | 2009-07-02 | Aga Medical Corporation | Percutaneous catheter directed intravascular occlusion devices |
US8858609B2 (en) | 2008-02-07 | 2014-10-14 | Intuitive Surgical Operations, Inc. | Stent delivery under direct visualization |
US20130165967A1 (en) | 2008-03-07 | 2013-06-27 | W.L. Gore & Associates, Inc. | Heart occlusion devices |
US20100256661A1 (en) * | 2009-04-06 | 2010-10-07 | Zeev Brandeis | Apparatus and method for enabling perforating vein ablation |
WO2009132045A2 (en) | 2008-04-21 | 2009-10-29 | Nfocus Neuromedical, Inc. | Braid-ball embolic devices and delivery systems |
CA2721950A1 (en) | 2008-04-25 | 2009-10-29 | Nellix, Inc. | Stent graft delivery system |
CA2722672C (en) | 2008-05-02 | 2019-10-22 | Sequent Medical Inc. | Filamentary devices for treatment of vascular defects |
US8454632B2 (en) | 2008-05-12 | 2013-06-04 | Xlumena, Inc. | Tissue anchor for securing tissue layers |
US20090281379A1 (en) | 2008-05-12 | 2009-11-12 | Xlumena, Inc. | System and method for transluminal access |
WO2009140437A1 (en) | 2008-05-13 | 2009-11-19 | Nfocus Neuromedical, Inc. | Braid implant delivery systems |
US9282965B2 (en) | 2008-05-16 | 2016-03-15 | Abbott Laboratories | Apparatus and methods for engaging tissue |
US8506490B2 (en) * | 2008-05-30 | 2013-08-13 | W.L. Gore & Associates, Inc. | Real time ultrasound probe |
WO2009149294A1 (en) | 2008-06-04 | 2009-12-10 | Nellix, Inc. | Sealing apparatus and methods of use |
US8591460B2 (en) | 2008-06-13 | 2013-11-26 | Cardiosolutions, Inc. | Steerable catheter and dilator and system and method for implanting a heart implant |
DE102008030631A1 (en) * | 2008-06-24 | 2009-12-31 | Würth Elektronik iBE GmbH | Electronic component |
US9101735B2 (en) | 2008-07-07 | 2015-08-11 | Intuitive Surgical Operations, Inc. | Catheter control systems |
WO2010006061A2 (en) * | 2008-07-11 | 2010-01-14 | Mayo Foundation For Medical Education And Research | Left atrial appendage occlusion devices |
AU2009274126A1 (en) | 2008-07-22 | 2010-01-28 | Covidien Lp | Vascular remodeling device |
US8585695B2 (en) * | 2008-07-22 | 2013-11-19 | Hue-Teh Shih | Systems and methods for noncontact ablation |
CA2734513C (en) * | 2008-08-18 | 2019-06-18 | Glenveigh Medical, Llc | Cervical occluder |
WO2010022180A1 (en) | 2008-08-19 | 2010-02-25 | Micro Therapeutics, Inc. | Detachable tip microcatheter |
US8308692B2 (en) * | 2008-09-03 | 2012-11-13 | Cook Incorporated | Introducer for use in inserting a medical device into a body vessel and method for same |
US10695126B2 (en) | 2008-10-06 | 2020-06-30 | Santa Anna Tech Llc | Catheter with a double balloon structure to generate and apply a heated ablative zone to tissue |
US8894643B2 (en) | 2008-10-10 | 2014-11-25 | Intuitive Surgical Operations, Inc. | Integral electrode placement and connection systems |
US8333012B2 (en) | 2008-10-10 | 2012-12-18 | Voyage Medical, Inc. | Method of forming electrode placement and connection systems |
CA2740867C (en) | 2008-10-16 | 2018-06-12 | Aptus Endosystems, Inc. | Devices, systems, and methods for endovascular staple and/or prosthesis delivery and implantation |
US8398676B2 (en) | 2008-10-30 | 2013-03-19 | Abbott Vascular Inc. | Closure device |
US8246648B2 (en) | 2008-11-10 | 2012-08-21 | Cook Medical Technologies Llc | Removable vena cava filter with improved leg |
US9468364B2 (en) | 2008-11-14 | 2016-10-18 | Intuitive Surgical Operations, Inc. | Intravascular catheter with hood and image processing systems |
US8858594B2 (en) | 2008-12-22 | 2014-10-14 | Abbott Laboratories | Curved closure device |
US8323312B2 (en) | 2008-12-22 | 2012-12-04 | Abbott Laboratories | Closure device |
US9414820B2 (en) | 2009-01-09 | 2016-08-16 | Abbott Vascular Inc. | Closure devices, systems, and methods |
US9486191B2 (en) | 2009-01-09 | 2016-11-08 | Abbott Vascular, Inc. | Closure devices |
US9173644B2 (en) | 2009-01-09 | 2015-11-03 | Abbott Vascular Inc. | Closure devices, systems, and methods |
US9089311B2 (en) | 2009-01-09 | 2015-07-28 | Abbott Vascular Inc. | Vessel closure devices and methods |
US20100179589A1 (en) | 2009-01-09 | 2010-07-15 | Abbott Vascular Inc. | Rapidly eroding anchor |
US9393023B2 (en) | 2009-01-13 | 2016-07-19 | Atricure, Inc. | Apparatus and methods for deploying a clip to occlude an anatomical structure |
US20100185234A1 (en) | 2009-01-16 | 2010-07-22 | Abbott Vascular Inc. | Closure devices, systems, and methods |
JP2012515624A (en) * | 2009-01-22 | 2012-07-12 | セント・ジュード・メディカル,カーディオロジー・ディヴィジョン,インコーポレイテッド | Postoperative adjustment tool, minimally invasive mounting device, and adjustable tricuspid valve ring |
WO2010115030A1 (en) | 2009-04-01 | 2010-10-07 | Sentreheart, Inc. | Tissue ligation devices and controls therefor |
CN102458264B (en) | 2009-04-09 | 2015-04-22 | 心血管科技股份有限公司 | Tissue closure devices, device and systems for delivery, kits and methods therefor |
JP5535313B2 (en) | 2009-05-29 | 2014-07-02 | エックスルミナ, インコーポレイテッド | Device and method for deploying a stent across adjacent tissue layers |
US9693781B2 (en) | 2009-06-17 | 2017-07-04 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US9649115B2 (en) | 2009-06-17 | 2017-05-16 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US10064628B2 (en) | 2009-06-17 | 2018-09-04 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US10631969B2 (en) | 2009-06-17 | 2020-04-28 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
EP2442728B1 (en) | 2009-06-17 | 2018-07-25 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage |
US20120029556A1 (en) | 2009-06-22 | 2012-02-02 | Masters Steven J | Sealing device and delivery system |
US8956389B2 (en) | 2009-06-22 | 2015-02-17 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
US9381006B2 (en) * | 2009-06-22 | 2016-07-05 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
JP5186042B2 (en) * | 2009-07-10 | 2013-04-17 | テウーン メディカル カンパニー リミティッド | Stent |
US20110054492A1 (en) | 2009-08-26 | 2011-03-03 | Abbott Laboratories | Medical device for repairing a fistula |
US20110082495A1 (en) * | 2009-10-02 | 2011-04-07 | Ruiz Carlos E | Apparatus And Methods For Excluding The Left Atrial Appendage |
AU2010315535A1 (en) | 2009-10-26 | 2012-05-03 | Cardiokinetix, Inc. | Ventricular volume reduction |
US9981108B2 (en) | 2009-10-30 | 2018-05-29 | Recor Medical, Inc. | Method and apparatus for treatment of hypertension through percutaneous ultrasound renal denervation |
WO2011057002A2 (en) | 2009-11-05 | 2011-05-12 | Sequent Medical Inc. | Multiple layer filamentary devices or treatment of vascular defects |
WO2011057277A2 (en) | 2009-11-09 | 2011-05-12 | Nfocus Neuromedical, Inc. | Braid ball embolic device features |
US20110276078A1 (en) | 2009-12-30 | 2011-11-10 | Nellix, Inc. | Filling structure for a graft system and methods of use |
US8926681B2 (en) | 2010-01-28 | 2015-01-06 | Covidien Lp | Vascular remodeling device |
EP2528542A4 (en) | 2010-01-28 | 2013-07-03 | Covidien Lp | Vascular remodeling device |
US8694071B2 (en) | 2010-02-12 | 2014-04-08 | Intuitive Surgical Operations, Inc. | Image stabilization techniques and methods |
US8303624B2 (en) | 2010-03-15 | 2012-11-06 | Abbott Cardiovascular Systems, Inc. | Bioabsorbable plug |
US9814522B2 (en) | 2010-04-06 | 2017-11-14 | Intuitive Surgical Operations, Inc. | Apparatus and methods for ablation efficacy |
CA2796269A1 (en) | 2010-04-13 | 2011-10-20 | Sentreheart, Inc. | Methods and devices for accessing and delivering devices to a heart |
US11419632B2 (en) | 2010-04-23 | 2022-08-23 | Mark D. Wieczorek, P.C. | Transseptal access device and method of use |
WO2011133977A2 (en) | 2010-04-23 | 2011-10-27 | Assist Medical Llc | Transseptal access device and method of use |
US10220134B2 (en) | 2010-04-23 | 2019-03-05 | Mark D. Wieczorek | Transseptal access device and method of use |
US8828051B2 (en) | 2010-07-02 | 2014-09-09 | Pfm Medical Ag | Left atrial appendage occlusion device |
US8758399B2 (en) | 2010-08-02 | 2014-06-24 | Abbott Cardiovascular Systems, Inc. | Expandable bioabsorbable plug apparatus and method |
US8603116B2 (en) | 2010-08-04 | 2013-12-10 | Abbott Cardiovascular Systems, Inc. | Closure device with long tines |
EP2613735B1 (en) | 2010-09-10 | 2018-05-09 | Covidien LP | Devices for the treatment of vascular defects |
US8998947B2 (en) | 2010-09-10 | 2015-04-07 | Medina Medical, Inc. | Devices and methods for the treatment of vascular defects |
US9017349B2 (en) | 2010-10-27 | 2015-04-28 | Atricure, Inc. | Appendage clamp deployment assist device |
US9066741B2 (en) | 2010-11-01 | 2015-06-30 | Atricure, Inc. | Robotic toolkit |
US8636754B2 (en) | 2010-11-11 | 2014-01-28 | Atricure, Inc. | Clip applicator |
US9186152B2 (en) * | 2010-11-12 | 2015-11-17 | W. L. Gore & Associates, Inc. | Left atrial appendage occlusive devices |
US10022212B2 (en) | 2011-01-13 | 2018-07-17 | Cook Medical Technologies Llc | Temporary venous filter with anti-coagulant delivery method |
RU2018131107A (en) | 2011-01-17 | 2018-10-31 | Метэктив Медикал, Инк. | DEVICE AND METHOD OF DELIVERY OF SEPARABLE METAL CYLINDER |
US11484318B2 (en) | 2011-01-17 | 2022-11-01 | Artio Medical, Inc. | Expandable body device and method of use |
US8801768B2 (en) | 2011-01-21 | 2014-08-12 | Endologix, Inc. | Graft systems having semi-permeable filling structures and methods for their use |
US20120283585A1 (en) * | 2011-02-10 | 2012-11-08 | Werneth Randell L | Atrial Appendage Occlusion and Arrhythmia Treatment |
CA2825774C (en) | 2011-02-11 | 2017-02-28 | Frank P. Becking | Two-stage deployment aneurysm embolization devices |
US9149276B2 (en) | 2011-03-21 | 2015-10-06 | Abbott Cardiovascular Systems, Inc. | Clip and deployment apparatus for tissue closure |
US9089332B2 (en) | 2011-03-25 | 2015-07-28 | Covidien Lp | Vascular remodeling device |
US9744033B2 (en) | 2011-04-01 | 2017-08-29 | W.L. Gore & Associates, Inc. | Elastomeric leaflet for prosthetic heart valves |
WO2012139054A1 (en) | 2011-04-06 | 2012-10-11 | Endologix, Inc. | Method and system for endovascular aneurysm treatment |
CA2835427A1 (en) | 2011-05-11 | 2012-11-15 | Microvention, Inc. | Device for occluding a lumen |
CN102805654B (en) * | 2011-06-01 | 2014-04-02 | 先健科技(深圳)有限公司 | Occluder for left auricle |
BR112013031390A2 (en) | 2011-06-08 | 2016-12-06 | Sentreheart Inc | fabric binding devices and tensioning devices therefor |
US10117765B2 (en) | 2011-06-14 | 2018-11-06 | W.L. Gore Associates, Inc | Apposition fiber for use in endoluminal deployment of expandable implants |
US8764793B2 (en) | 2011-06-17 | 2014-07-01 | Northwestern University | Left atrial appendage occluder |
US10799360B2 (en) | 2011-07-27 | 2020-10-13 | The Cleveland Clinic Foundation | Systems and methods for treating a regurgitant heart valve |
WO2013016618A2 (en) | 2011-07-27 | 2013-01-31 | The Cleveland Clinic Foundation | Apparatus, system, and method for treating a regurgitant heart valve |
US9770232B2 (en) | 2011-08-12 | 2017-09-26 | W. L. Gore & Associates, Inc. | Heart occlusion devices |
CA2844687C (en) | 2011-08-15 | 2021-05-25 | Atricure Inc. | Surgical device |
JP6240604B2 (en) * | 2011-08-19 | 2017-11-29 | インセプタス メディカル リミテッド ライアビリティ カンパニー | Expandable occlusion device and method |
US9554806B2 (en) * | 2011-09-16 | 2017-01-31 | W. L. Gore & Associates, Inc. | Occlusive devices |
WO2013049448A1 (en) | 2011-09-29 | 2013-04-04 | Covidien Lp | Vascular remodeling device |
CA2855003C (en) | 2011-11-08 | 2019-01-15 | Boston Scientific Scimed, Inc. | Handle assembly for a left atrial appendage occlusion device |
US10219931B2 (en) * | 2011-11-09 | 2019-03-05 | Easynotes Ltd. | Obstruction device |
WO2013068466A1 (en) * | 2011-11-09 | 2013-05-16 | Universität Zürich | System for occluding a left atrial appendage |
WO2013071115A1 (en) | 2011-11-09 | 2013-05-16 | Boston Scientific Scimed, Inc. | Occlusion device |
US9877858B2 (en) | 2011-11-14 | 2018-01-30 | W. L. Gore & Associates, Inc. | External steerable fiber for use in endoluminal deployment of expandable devices |
US9782282B2 (en) | 2011-11-14 | 2017-10-10 | W. L. Gore & Associates, Inc. | External steerable fiber for use in endoluminal deployment of expandable devices |
US8758389B2 (en) | 2011-11-18 | 2014-06-24 | Aga Medical Corporation | Devices and methods for occluding abnormal openings in a patient's vasculature |
US9332976B2 (en) | 2011-11-30 | 2016-05-10 | Abbott Cardiovascular Systems, Inc. | Tissue closure device |
RU2014129392A (en) | 2012-01-06 | 2016-02-27 | Эмболайн, Инк. | Embedded anti-embolic protection |
KR102005053B1 (en) | 2012-01-17 | 2019-07-29 | 메타랙티브 메디컬, 인크. | Expandable body device and method of use |
US9282973B2 (en) | 2012-01-20 | 2016-03-15 | Atricure, Inc. | Clip deployment tool and associated methods |
EP2819586A2 (en) * | 2012-02-29 | 2015-01-07 | Vivasure Medical Limited | Percutaneous perforation closure systems, devices, and methods |
US20130237908A1 (en) * | 2012-03-09 | 2013-09-12 | Boston Scientific Scimed, Inc. | Sponge-like left atrial occlusion device and related methods of use |
US9375308B2 (en) | 2012-03-13 | 2016-06-28 | W. L. Gore & Associates, Inc. | External steerable fiber for use in endoluminal deployment of expandable devices |
EP2641569B1 (en) | 2012-03-23 | 2015-01-28 | Sorin Group Italia S.r.l. | A collapsible valve prosthesis |
US9821145B2 (en) | 2012-03-23 | 2017-11-21 | Pressure Products Medical Supplies Inc. | Transseptal puncture apparatus and method for using the same |
EP3957276A1 (en) | 2012-05-31 | 2022-02-23 | Javelin Medical Ltd. | Device for embolic protection |
US10124087B2 (en) | 2012-06-19 | 2018-11-13 | Covidien Lp | Detachable coupling for catheter |
EP3213695B1 (en) * | 2012-07-13 | 2021-05-05 | Boston Scientific Scimed, Inc. | Occlusion device for an atrial appendage |
US9155647B2 (en) | 2012-07-18 | 2015-10-13 | Covidien Lp | Methods and apparatus for luminal stenting |
CN104736103A (en) * | 2012-09-12 | 2015-06-24 | 波士顿科学国际有限公司 | Fixation anchor design for an occlusion device |
US9750595B2 (en) | 2012-09-28 | 2017-09-05 | Covidien Lp | Implantable medical devices which include grip-members and methods of use thereof |
US9314248B2 (en) | 2012-11-06 | 2016-04-19 | Covidien Lp | Multi-pivot thrombectomy device |
CN104918565B (en) | 2012-11-13 | 2018-04-27 | 柯惠有限合伙公司 | plugging device |
US20140163599A1 (en) * | 2012-12-06 | 2014-06-12 | Bandula Wijay | Lumen Occluding Stent, Delivery Catheter and Method |
US9364209B2 (en) | 2012-12-21 | 2016-06-14 | Abbott Cardiovascular Systems, Inc. | Articulating suturing device |
US9468443B2 (en) | 2012-12-27 | 2016-10-18 | Cook Medical Technologies Llc | Occlusion balloon |
US9295571B2 (en) | 2013-01-17 | 2016-03-29 | Covidien Lp | Methods and apparatus for luminal stenting |
ES2895968T3 (en) | 2013-01-18 | 2022-02-23 | Javelin Medical Ltd | Monofilament implants and systems for supplying the same |
US10828019B2 (en) | 2013-01-18 | 2020-11-10 | W.L. Gore & Associates, Inc. | Sealing device and delivery system |
WO2014127641A1 (en) | 2013-02-19 | 2014-08-28 | 湖南埃普特医疗器械有限公司 | Left atrial appendage plugging device and delivery system |
CN103099652B (en) * | 2013-02-19 | 2015-08-12 | 湖南埃普特医疗器械有限公司 | A kind of left atrial appendage occlusion device and a kind of induction system |
ES2813871T3 (en) | 2013-02-21 | 2021-03-25 | Boston Scient Scimed Inc | Devices to form an anastomosis |
CN108652701B (en) | 2013-03-12 | 2021-04-06 | 森特里心脏股份有限公司 | Tissue ligation device and method |
US10617425B2 (en) | 2014-03-10 | 2020-04-14 | Conformal Medical, Inc. | Devices and methods for excluding the left atrial appendage |
US9943315B2 (en) | 2013-03-13 | 2018-04-17 | Conformal Medical, Inc. | Devices and methods for excluding the left atrial appendage |
EP2968873A4 (en) | 2013-03-13 | 2016-10-26 | Applied Cardiovascular Solutions Llc | Methods, compositions, and devices for the occlusion of cavities and passageways |
US11399842B2 (en) | 2013-03-13 | 2022-08-02 | Conformal Medical, Inc. | Devices and methods for excluding the left atrial appendage |
US9463105B2 (en) | 2013-03-14 | 2016-10-11 | Covidien Lp | Methods and apparatus for luminal stenting |
EP2968984B1 (en) | 2013-03-14 | 2016-08-17 | ReCor Medical, Inc. | Ultrasound-based neuromodulation system |
US9289536B2 (en) | 2013-03-14 | 2016-03-22 | Endologix, Inc. | Method for forming materials in situ within a medical device |
CN108433769B (en) | 2013-03-15 | 2021-06-08 | 柯惠有限合伙公司 | Occlusion device |
EP3351218A1 (en) | 2013-03-15 | 2018-07-25 | Baronova, Inc. | Locking gastric obstruction device |
US9289297B2 (en) | 2013-03-15 | 2016-03-22 | Cardiosolutions, Inc. | Mitral valve spacer and system and method for implanting the same |
US9232998B2 (en) | 2013-03-15 | 2016-01-12 | Cardiosolutions Inc. | Trans-apical implant systems, implants and methods |
US9089414B2 (en) * | 2013-03-22 | 2015-07-28 | Edwards Lifesciences Corporation | Device and method for increasing flow through the left atrial appendage |
WO2014201452A1 (en) | 2013-06-14 | 2014-12-18 | Cardiosolutions, Inc. | Mitral valve spacer and system and method for implanting the same |
US10123805B2 (en) * | 2013-06-26 | 2018-11-13 | W. L. Gore & Associates, Inc. | Space filling devices |
US11911258B2 (en) | 2013-06-26 | 2024-02-27 | W. L. Gore & Associates, Inc. | Space filling devices |
US9955976B2 (en) | 2013-08-16 | 2018-05-01 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US9078658B2 (en) | 2013-08-16 | 2015-07-14 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US9526522B2 (en) | 2013-09-27 | 2016-12-27 | Medtronic, Inc. | Interventional medical systems, tools, and assemblies |
US10300286B2 (en) | 2013-09-27 | 2019-05-28 | Medtronic, Inc. | Tools and assemblies thereof for implantable medical devices |
GB2523291B (en) * | 2013-10-16 | 2016-02-24 | Cook Medical Technologies Llc | Vascular occluder with crossing frame elements |
WO2015061365A1 (en) | 2013-10-21 | 2015-04-30 | Inceptus Medical, Llc | Methods and apparatus for treating embolism |
EP4226881A1 (en) | 2013-10-31 | 2023-08-16 | AtriCure, Inc. | Device for left atrial appendage closure |
CN103598902B (en) | 2013-11-14 | 2017-01-25 | 先健科技(深圳)有限公司 | Left aurcle plugging device |
US10485545B2 (en) | 2013-11-19 | 2019-11-26 | Datascope Corp. | Fastener applicator with interlock |
US9592110B1 (en) | 2013-12-06 | 2017-03-14 | Javelin Medical, Ltd. | Systems and methods for implant delivery |
JP6661539B2 (en) | 2013-12-20 | 2020-03-11 | テルモ株式会社 | Vessel closure |
US9730701B2 (en) | 2014-01-16 | 2017-08-15 | Boston Scientific Scimed, Inc. | Retrieval wire centering device |
US10258343B2 (en) | 2014-01-27 | 2019-04-16 | Lifetech Scientific (Shenzhen) Co. Ltd. | Left atrial appendage occluder |
WO2015152741A1 (en) * | 2014-03-31 | 2015-10-08 | Jitmed Sp. Z.O.O. | Left atrial appendage occlusion device |
US9629635B2 (en) | 2014-04-14 | 2017-04-25 | Sequent Medical, Inc. | Devices for therapeutic vascular procedures |
US10405866B2 (en) | 2014-04-25 | 2019-09-10 | Flow MedTech, Inc | Left atrial appendage occlusion device |
EP3970635A1 (en) | 2014-04-30 | 2022-03-23 | Cerus Endovascular Limited | Occlusion device |
US9808230B2 (en) | 2014-06-06 | 2017-11-07 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
CN106413589A (en) * | 2014-06-11 | 2017-02-15 | 奥特鲁泰克控股有限公司 | Left atrial appendage occluder |
CN105326536A (en) * | 2014-08-12 | 2016-02-17 | 徐州亚太科技有限公司 | Percutaneous left atrial appendage occluder |
US9675798B2 (en) | 2014-08-26 | 2017-06-13 | Medtronic, Inc. | Interventional medical systems, devices, and components thereof |
US10478620B2 (en) | 2014-08-26 | 2019-11-19 | Medtronic, Inc. | Interventional medical systems, devices, and methods of use |
CN105434082A (en) * | 2014-09-16 | 2016-03-30 | 徐州亚太科技有限公司 | Left auricle plugging device |
CN107530090B (en) | 2014-09-17 | 2021-03-09 | 阿提奥医疗公司 | Expandable body device and method of use |
CA2999169A1 (en) | 2014-09-19 | 2016-03-24 | Flow Medtech, Inc. | Left atrial appendage occlusion device delivery system |
CN106852115A (en) | 2014-09-28 | 2017-06-13 | 卡迪欧凯尼迪克斯公司 | device for treating cardiac insufficiency |
CN104306040B (en) * | 2014-10-09 | 2017-04-26 | 上海形状记忆合金材料有限公司 | Left atrial appendage plugging device |
CN105796148B (en) * | 2014-12-31 | 2018-06-05 | 先健科技(深圳)有限公司 | Occluder for left auricle |
CN107405152B (en) | 2015-02-10 | 2021-04-09 | 波士顿科学国际有限公司 | Vascular occlusion device |
CN104688292B (en) * | 2015-02-15 | 2017-08-25 | 上海形状记忆合金材料有限公司 | A kind of left atrial appendage occlusion device and plugging system |
EP3258857B1 (en) | 2015-02-18 | 2023-07-26 | Boston Scientific Scimed, Inc. | Vascular occlusion devices |
CN107530523B (en) * | 2015-02-25 | 2021-03-19 | 盖乐西医疗公司 | System for treating aneurysm |
US9375333B1 (en) | 2015-03-06 | 2016-06-28 | Covidien Lp | Implantable device detachment systems and associated devices and methods |
EP3273870B1 (en) | 2015-03-24 | 2023-12-13 | AtriCure, Inc. | Tissue ligation devices |
CN107530070B (en) | 2015-03-24 | 2021-09-28 | 森特里心脏股份有限公司 | Device and method for left atrial appendage closure |
CN106137292B (en) * | 2015-04-10 | 2019-02-22 | 上海市同济医院 | A kind of device for left auricle of heart ligation operation |
WO2016183495A2 (en) | 2015-05-14 | 2016-11-17 | W. L. Gore & Associates, Inc. | Devices and methods for occlusion of an atrial appendage |
US10548579B2 (en) | 2015-07-29 | 2020-02-04 | Cardiac Pacemakers, Inc. | Left atrial appendage implant |
EP3340890B1 (en) * | 2015-08-25 | 2022-07-06 | University Of Louisville Research Foundation, Inc. | Atrial appendage closure device |
US10478194B2 (en) | 2015-09-23 | 2019-11-19 | Covidien Lp | Occlusive devices |
EP4233744A3 (en) | 2015-10-23 | 2023-11-01 | Inari Medical, Inc. | Device for intravascular treatment of vascular occlusion |
CN108882941B (en) | 2015-11-13 | 2021-08-24 | 心脏起搏器公司 | Bioabsorbable left atrial appendage closure with endothelialization-promoting surface |
JP6892188B2 (en) | 2015-12-07 | 2021-06-23 | シーラス エンドバスキュラー リミテッド | Blocking device |
CN106901792B (en) | 2015-12-29 | 2019-11-01 | 深圳市科奕顿生物医疗科技有限公司 | Occluder for left auricle |
CN106923884B (en) * | 2015-12-31 | 2018-12-21 | 先健科技(深圳)有限公司 | Occluder for left auricle |
US10729447B2 (en) * | 2016-02-10 | 2020-08-04 | Microvention, Inc. | Devices for vascular occlusion |
JP7137472B2 (en) | 2016-02-26 | 2022-09-14 | センターハート・インコーポレイテッド | Device and method for left atrial appendage closure |
CA3016679A1 (en) | 2016-03-11 | 2017-09-14 | Cerus Endovascular Limited | Occlusion device |
CN107303190B (en) * | 2016-04-21 | 2021-06-08 | 姜昕 | Left auricle thrombus isolating device |
US10143823B2 (en) | 2016-04-29 | 2018-12-04 | Medtronic, Inc. | Interventional medical systems and improved assemblies thereof and associated methods of use |
US11331140B2 (en) | 2016-05-19 | 2022-05-17 | Aqua Heart, Inc. | Heated vapor ablation systems and methods for treating cardiac conditions |
US10736632B2 (en) * | 2016-07-06 | 2020-08-11 | Evalve, Inc. | Methods and devices for valve clip excision |
EP4129210A1 (en) | 2016-07-22 | 2023-02-08 | Cornell University | Left atrial appendage occluder device |
CN106137299B (en) * | 2016-08-03 | 2019-12-13 | 南京友德邦医疗科技有限公司 | Plugging device for left auricle |
US10478195B2 (en) | 2016-08-04 | 2019-11-19 | Covidien Lp | Devices, systems, and methods for the treatment of vascular defects |
US9994980B2 (en) | 2016-10-14 | 2018-06-12 | Inceptus Medical, Llc | Braiding machine and methods of use |
CN107970053B (en) * | 2016-10-21 | 2022-01-28 | 上海佐心医疗科技有限公司 | Left auricle plugging device |
JP7222886B2 (en) | 2016-10-21 | 2023-02-15 | ジャベリン メディカル リミテッド | Systems, methods, and devices for embolic protection |
WO2018080590A1 (en) | 2016-10-24 | 2018-05-03 | Inari Medical | Devices and methods for treating vascular occlusion |
US11426172B2 (en) | 2016-10-27 | 2022-08-30 | Conformal Medical, Inc. | Devices and methods for excluding the left atrial appendage |
EP3531926A2 (en) | 2016-10-27 | 2019-09-04 | Conformal Medical, Inc. | Devices and methods for excluding the left atrial appendage |
US10583301B2 (en) | 2016-11-08 | 2020-03-10 | Cardiac Pacemakers, Inc. | Implantable medical device for atrial deployment |
US10653523B2 (en) * | 2017-01-19 | 2020-05-19 | 4C Medical Technologies, Inc. | Systems, methods and devices for delivery systems, methods and devices for implanting prosthetic heart valves |
US10561495B2 (en) | 2017-01-24 | 2020-02-18 | 4C Medical Technologies, Inc. | Systems, methods and devices for two-step delivery and implantation of prosthetic heart valve |
CN110573092B (en) | 2017-02-24 | 2023-04-18 | 因赛普特斯医学有限责任公司 | Vasoocclusive devices and methods |
JP6905220B2 (en) * | 2017-03-08 | 2021-07-21 | 国立大学法人 大分大学 | Balloon position confirmation system |
US10898330B2 (en) | 2017-03-28 | 2021-01-26 | Edwards Lifesciences Corporation | Positioning, deploying, and retrieving implantable devices |
WO2018185255A1 (en) * | 2017-04-05 | 2018-10-11 | National University Of Ireland, Galway | An implantable medical device |
EP3612103B1 (en) * | 2017-04-20 | 2022-02-09 | Medtronic, Inc. | Stabilization of a transseptal delivery device |
WO2018200891A1 (en) | 2017-04-27 | 2018-11-01 | Boston Scientific Scimed, Inc. | Occlusive medical device with fabric retention barb |
US11812968B2 (en) | 2017-05-10 | 2023-11-14 | Lifetech Scientific (Shenzhen) Co. Ltd. | Left atrial appendage occluder |
EP3403596A1 (en) | 2017-05-16 | 2018-11-21 | Universitätsklinikum Jena | Implantation and anchorage system for an atrial occluder |
WO2018218210A1 (en) | 2017-05-25 | 2018-11-29 | Microvention, Inc. | Adhesive occlusion systems |
CN108938036B (en) * | 2017-05-27 | 2023-12-05 | 无锡市第二人民医院 | Glue injection and left auricle blocking device with blocking saccule at front end |
CN108926366B (en) * | 2017-05-27 | 2023-12-22 | 无锡市第二人民医院 | Rubber injection plugging left auricle device with nickel-titanium alloy mesh cover at front end |
CN108969030B (en) * | 2017-06-02 | 2022-01-07 | 上海佐心医疗科技有限公司 | Medical device |
WO2019038293A1 (en) | 2017-08-21 | 2019-02-28 | Cerus Endovascular Limited | Occlusion device |
US10675036B2 (en) | 2017-08-22 | 2020-06-09 | Covidien Lp | Devices, systems, and methods for the treatment of vascular defects |
WO2019050765A1 (en) | 2017-09-06 | 2019-03-14 | Inari Medical, Inc. | Hemostasis valves and methods of use |
EP3694571A1 (en) | 2017-10-10 | 2020-08-19 | The Texas A&M University System | Sheathed embolization device |
JP7429187B2 (en) | 2017-10-14 | 2024-02-07 | インセプタス メディカル リミテッド ライアビリティ カンパニー | Braiding machine and usage |
US11173023B2 (en) | 2017-10-16 | 2021-11-16 | W. L. Gore & Associates, Inc. | Medical devices and anchors therefor |
US11020123B2 (en) | 2017-10-27 | 2021-06-01 | Boston Scientific Scimed, Inc. | Occlusive medical device with cushioning member |
US20190167242A1 (en) * | 2017-12-04 | 2019-06-06 | Edwards Lifesciences Corporation | Devices and methods for closing a left atrial appendage |
US10952741B2 (en) | 2017-12-18 | 2021-03-23 | Boston Scientific Scimed, Inc. | Occlusive device with expandable member |
US11413048B2 (en) | 2018-01-19 | 2022-08-16 | Boston Scientific Scimed, Inc. | Occlusive medical device with delivery system |
US11154314B2 (en) | 2018-01-26 | 2021-10-26 | Inari Medical, Inc. | Single insertion delivery system for treating embolism and associated systems and methods |
JP2020537563A (en) * | 2018-02-09 | 2020-12-24 | 4テック インコーポレイテッド | Frustrated cone-shaped hemostatic seal element |
WO2019161072A1 (en) | 2018-02-14 | 2019-08-22 | Boston Scientific Scimed, Inc. | Occlusive medical device |
CN110313945B (en) * | 2018-03-28 | 2021-09-28 | 上海微创医疗器械(集团)有限公司 | Plugging device and preparation method thereof |
JP7348199B2 (en) | 2018-03-28 | 2023-09-20 | データスコープ コーポレイション | Device for atrial appendage exclusion |
WO2019213274A1 (en) | 2018-05-02 | 2019-11-07 | Boston Scientific Scimed, Inc. | Occlusive sealing sensor system |
EP3793450A1 (en) | 2018-05-15 | 2021-03-24 | Boston Scientific Scimed, Inc. | Occlusive medical device with charged polymer coating |
US11123079B2 (en) | 2018-06-08 | 2021-09-21 | Boston Scientific Scimed, Inc. | Occlusive device with actuatable fixation members |
EP3801300A1 (en) | 2018-06-08 | 2021-04-14 | Boston Scientific Scimed, Inc. | Medical device with occlusive member |
CN112566566A (en) | 2018-07-06 | 2021-03-26 | 波士顿科学医学有限公司 | Closed medical device |
EP3836855A4 (en) | 2018-08-13 | 2022-08-10 | Inari Medical, Inc. | System for treating embolism and associated devices and methods |
EP3840670B1 (en) | 2018-08-21 | 2023-11-15 | Boston Scientific Scimed, Inc. | Projecting member with barb for cardiovascular devices |
US11857441B2 (en) | 2018-09-04 | 2024-01-02 | 4C Medical Technologies, Inc. | Stent loading device |
WO2020056058A1 (en) | 2018-09-13 | 2020-03-19 | Ozgur Kocaturk | Devices and methods for closing openings in tissue structures |
CN110960279B (en) * | 2018-09-29 | 2023-06-16 | 上海佐心医疗科技有限公司 | Left auricle plugging device and left auricle plugging system |
EP3636172A1 (en) | 2018-10-11 | 2020-04-15 | Aurigen Medical Limited | A device for accessing the epicardial space |
WO2020093012A1 (en) | 2018-11-01 | 2020-05-07 | Terumo Corporation | Occlusion systems |
EP3893763A1 (en) * | 2018-12-10 | 2021-10-20 | Boston Scientific Scimed Inc. | Left atrial appendage implant with sealing balloon |
WO2020131975A2 (en) | 2018-12-17 | 2020-06-25 | Covidien Lp | Devices, systems, and methods for the treatment of vascular defects |
WO2020163507A1 (en) * | 2019-02-08 | 2020-08-13 | Conformal Medical, Inc. | Devices and methods for excluding the left atrial appendage |
JP2022520573A (en) | 2019-02-13 | 2022-03-31 | エンボライン, インコーポレイテッド | Catheter with integrated embolic protection device |
US11317921B2 (en) | 2019-03-15 | 2022-05-03 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
EP3908209A4 (en) | 2019-03-15 | 2022-10-19 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US11291453B2 (en) | 2019-03-15 | 2022-04-05 | Sequent Medical, Inc. | Filamentary devices having a flexible joint for treatment of vascular defects |
US10856880B1 (en) | 2019-05-25 | 2020-12-08 | Galaxy Therapeutics, Inc. | Systems and methods for treating aneurysms |
US11369355B2 (en) * | 2019-06-17 | 2022-06-28 | Coherex Medical, Inc. | Medical device and system for occluding a tissue opening and method thereof |
CN114258290A (en) * | 2019-07-02 | 2022-03-29 | 附加医疗有限公司 | Left atrial appendage manipulation |
WO2021011694A1 (en) | 2019-07-17 | 2021-01-21 | Boston Scientific Scimed, Inc. | Left atrial appendage implant with continuous covering |
WO2021041831A1 (en) | 2019-08-30 | 2021-03-04 | Boston Scientific Scimed, Inc. | Left atrial appendage implant with sealing disk |
WO2021058555A1 (en) * | 2019-09-23 | 2021-04-01 | Biotronik Se & Co. Kg | A system for holding an active implant in an atrial appendage of a heart and methods for implanting an active implant |
US11864779B2 (en) | 2019-10-16 | 2024-01-09 | Inari Medical, Inc. | Systems, devices, and methods for treating vascular occlusions |
KR102428283B1 (en) * | 2019-11-01 | 2022-08-02 | 사회복지법인 삼성생명공익재단 | Embolic apparatus |
US11685007B2 (en) | 2019-11-04 | 2023-06-27 | Covidien Lp | Devices, systems, and methods for treatment of intracranial aneurysms |
EP3851054A1 (en) | 2020-01-17 | 2021-07-21 | Universität Zürich | Occluder device |
US11931253B2 (en) | 2020-01-31 | 2024-03-19 | 4C Medical Technologies, Inc. | Prosthetic heart valve delivery system: ball-slide attachment |
US11406404B2 (en) | 2020-02-20 | 2022-08-09 | Cerus Endovascular Limited | Clot removal distal protection methods |
WO2021195085A1 (en) | 2020-03-24 | 2021-09-30 | Boston Scientific Scimed, Inc. | Medical system for treating a left atrial appendage |
US11931041B2 (en) | 2020-05-12 | 2024-03-19 | Covidien Lp | Devices, systems, and methods for the treatment of vascular defects |
CN116113372A (en) * | 2020-06-25 | 2023-05-12 | 斯奎德拉生命科学公司 | Method and device for occluding the left atrial appendage |
CN112120751A (en) * | 2020-10-22 | 2020-12-25 | 于洪波 | Interventional blood vessel hemostasis device for medical operation |
US11812969B2 (en) | 2020-12-03 | 2023-11-14 | Coherex Medical, Inc. | Medical device and system for occluding a tissue opening and method thereof |
Family Cites Families (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3638652A (en) * | 1970-06-01 | 1972-02-01 | James L Kelley | Surgical instrument for intraluminal anastomosis |
US3844302A (en) * | 1970-09-14 | 1974-10-29 | Telesco Brophey Ltd | Collapsible umbrella |
US3874388A (en) * | 1973-02-12 | 1975-04-01 | Ochsner Med Found Alton | Shunt defect closure system |
US4007743A (en) * | 1975-10-20 | 1977-02-15 | American Hospital Supply Corporation | Opening mechanism for umbrella-like intravascular shunt defect closure device |
US4603693A (en) * | 1977-05-26 | 1986-08-05 | United States Surgical Corporation | Instrument for circular surgical stapling of hollow body organs and disposable cartridge therefor |
US4341218A (en) * | 1978-05-30 | 1982-07-27 | University Of California | Detachable balloon catheter |
US4665906A (en) * | 1983-10-14 | 1987-05-19 | Raychem Corporation | Medical devices incorporating sim alloy elements |
US4710192A (en) * | 1985-12-30 | 1987-12-01 | Liotta Domingo S | Diaphragm and method for occlusion of the descending thoracic aorta |
EP0352325A4 (en) * | 1988-01-12 | 1990-05-14 | Ki Nii Nejrokhirurgii | Occluding device. |
US4921484A (en) * | 1988-07-25 | 1990-05-01 | Cordis Corporation | Mesh balloon catheter device |
US4917089A (en) * | 1988-08-29 | 1990-04-17 | Sideris Eleftherios B | Buttoned device for the transvenous occlusion of intracardiac defects |
FR2641692A1 (en) * | 1989-01-17 | 1990-07-20 | Nippon Zeon Co | Plug for closing an opening for a medical application, and device for the closure plug making use thereof |
US5171259A (en) * | 1990-04-02 | 1992-12-15 | Kanji Inoue | Device for nonoperatively occluding a defect |
US5078736A (en) * | 1990-05-04 | 1992-01-07 | Interventional Thermodynamics, Inc. | Method and apparatus for maintaining patency in the body passages |
US5064435A (en) * | 1990-06-28 | 1991-11-12 | Schneider (Usa) Inc. | Self-expanding prosthesis having stable axial length |
US5042707A (en) * | 1990-10-16 | 1991-08-27 | Taheri Syde A | Intravascular stapler, and method of operating same |
US5108420A (en) * | 1991-02-01 | 1992-04-28 | Temple University | Aperture occlusion device |
SE467948B (en) * | 1991-06-14 | 1992-10-12 | Ams Medinvent Sa | DEVICE FOR TRANSLUMINAL REMOVAL OR IMPLANTATION OF A STENT AND APPARATUS INCLUDING A SOUND DEVICE |
US5735290A (en) * | 1993-02-22 | 1998-04-07 | Heartport, Inc. | Methods and systems for performing thoracoscopic coronary bypass and other procedures |
EP0545091B1 (en) * | 1991-11-05 | 1999-07-07 | The Children's Medical Center Corporation | Occluder for repair of cardiac and vascular defects |
CA2082090C (en) * | 1991-11-05 | 2004-04-27 | Jack Fagan | Improved occluder for repair of cardiac and vascular defects |
US5176692A (en) * | 1991-12-09 | 1993-01-05 | Wilk Peter J | Method and surgical instrument for repairing hernia |
US5258042A (en) * | 1991-12-16 | 1993-11-02 | Henry Ford Health System | Intravascular hydrogel implant |
CA2128338C (en) * | 1992-01-21 | 2004-10-12 | Gladwin S. Das | Septal defect closure device |
FR2689388B1 (en) * | 1992-04-07 | 1999-07-16 | Celsa Lg | PERFECTIONALLY RESORBABLE BLOOD FILTER. |
US5527338A (en) * | 1992-09-02 | 1996-06-18 | Board Of Regents, The University Of Texas System | Intravascular device |
US5443454A (en) * | 1992-12-09 | 1995-08-22 | Terumo Kabushiki Kaisha | Catheter for embolectomy |
US5417699A (en) * | 1992-12-10 | 1995-05-23 | Perclose Incorporated | Device and method for the percutaneous suturing of a vascular puncture site |
US5284488A (en) * | 1992-12-23 | 1994-02-08 | Sideris Eleftherios B | Adjustable devices for the occlusion of cardiac defects |
US5306234A (en) * | 1993-03-23 | 1994-04-26 | Johnson W Dudley | Method for closing an atrial appendage |
US5527322A (en) * | 1993-11-08 | 1996-06-18 | Perclose, Inc. | Device and method for suturing of internal puncture sites |
US5490856A (en) * | 1993-12-14 | 1996-02-13 | Untied States Surgical Corporation | Purse string stapler |
US5522836A (en) * | 1994-06-27 | 1996-06-04 | Target Therapeutics, Inc. | Electrolytically severable coil assembly with movable detachment point |
US5725552A (en) * | 1994-07-08 | 1998-03-10 | Aga Medical Corporation | Percutaneous catheter directed intravascular occlusion devices |
US5433727A (en) * | 1994-08-16 | 1995-07-18 | Sideris; Eleftherios B. | Centering buttoned device for the occlusion of large defects for occluding |
US5643292A (en) * | 1995-01-10 | 1997-07-01 | Applied Medical Resources Corporation | Percutaneous suturing device |
US5702421A (en) * | 1995-01-11 | 1997-12-30 | Schneidt; Bernhard | Closure device for closing a vascular opening, such as patent ductus arteriosus |
US5614204A (en) * | 1995-01-23 | 1997-03-25 | The Regents Of The University Of California | Angiographic vascular occlusion agents and a method for hemostatic occlusion |
US5634936A (en) * | 1995-02-06 | 1997-06-03 | Scimed Life Systems, Inc. | Device for closing a septal defect |
US5849005A (en) * | 1995-06-07 | 1998-12-15 | Heartport, Inc. | Method and apparatus for minimizing the risk of air embolism when performing a procedure in a patient's thoracic cavity |
US5645558A (en) * | 1995-04-20 | 1997-07-08 | Medical University Of South Carolina | Anatomically shaped vasoocclusive device and method of making the same |
US5709224A (en) * | 1995-06-07 | 1998-01-20 | Radiotherapeutics Corporation | Method and device for permanent vessel occlusion |
US6132438A (en) * | 1995-06-07 | 2000-10-17 | Ep Technologies, Inc. | Devices for installing stasis reducing means in body tissue |
US5725568A (en) * | 1995-06-27 | 1998-03-10 | Scimed Life Systems, Inc. | Method and device for recanalizing and grafting arteries |
DE69612507T2 (en) * | 1995-10-30 | 2001-08-09 | Childrens Medical Center | SELF-CENTERING, SHIELD-LIKE DEVICE FOR CLOSING A SEPTAL DEFECT |
US5749894A (en) * | 1996-01-18 | 1998-05-12 | Target Therapeutics, Inc. | Aneurysm closure method |
US5733294A (en) * | 1996-02-28 | 1998-03-31 | B. Braun Medical, Inc. | Self expanding cardiovascular occlusion device, method of using and method of making the same |
US5906207A (en) * | 1996-04-04 | 1999-05-25 | Merck & Co., Inc. | Method for simulating heart failure |
CN2254330Y (en) * | 1996-04-12 | 1997-05-21 | 王永武 | Plugging device for patent arterial ductus |
US5830228A (en) * | 1996-05-29 | 1998-11-03 | Urosurge, Inc. | Methods and systems for deployment of a detachable balloon at a target site in vivo |
US5669933A (en) * | 1996-07-17 | 1997-09-23 | Nitinol Medical Technologies, Inc. | Removable embolus blood clot filter |
US5776097A (en) * | 1996-12-19 | 1998-07-07 | University Of California At Los Angeles | Method and device for treating intracranial vascular aneurysms |
US5782860A (en) * | 1997-02-11 | 1998-07-21 | Biointerventional Corporation | Closure device for percutaneous occlusion of puncture sites and tracts in the human body and method |
US5935148A (en) * | 1998-06-24 | 1999-08-10 | Target Therapeutics, Inc. | Detachable, varying flexibility, aneurysm neck bridge |
-
1998
- 1998-11-06 US US09/187,200 patent/US6152144A/en not_active Expired - Lifetime
-
1999
- 1999-11-08 AT AT99960236T patent/ATE512630T1/en not_active IP Right Cessation
- 1999-11-08 JP JP2000580529A patent/JP2003529384A/en active Pending
- 1999-11-08 ES ES99960236T patent/ES2367414T3/en not_active Expired - Lifetime
- 1999-11-08 AU AU17153/00A patent/AU771096B2/en not_active Ceased
- 1999-11-08 CA CA002349667A patent/CA2349667C/en not_active Expired - Fee Related
- 1999-11-08 WO PCT/US1999/026325 patent/WO2000027292A1/en active IP Right Grant
- 1999-11-08 EP EP99960236A patent/EP1135068B1/en not_active Expired - Lifetime
- 1999-11-08 CN CNB998154539A patent/CN100394895C/en not_active Expired - Fee Related
-
2002
- 2002-09-27 HK HK02107141.1A patent/HK1045452B/en not_active IP Right Cessation
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9017394B2 (en) | 1999-08-09 | 2015-04-28 | Cardiokinetix, Inc. | Retrievable cardiac devices |
US8974484B2 (en) | 2001-09-11 | 2015-03-10 | Spiration, Inc. | Removable lung reduction devices, systems, and methods |
US8926647B2 (en) | 2002-03-20 | 2015-01-06 | Spiration, Inc. | Removable anchored lung volume reduction devices and methods |
US9241695B2 (en) | 2002-03-25 | 2016-01-26 | W.L. Gore & Associates, Inc. | Patent foramen ovale (PFO) closure clips |
US9216014B2 (en) | 2002-06-03 | 2015-12-22 | W.L. Gore & Associates, Inc. | Device with biological tissue scaffold for percutaneous closure of an intracardiac defect and methods thereof |
US8974527B2 (en) | 2003-08-08 | 2015-03-10 | Spiration, Inc. | Bronchoscopic repair of air leaks in a lung |
US8926603B2 (en) | 2004-03-05 | 2015-01-06 | Hansen Medical, Inc. | System and method for denaturing and fixing collagenous tissue |
US9545247B2 (en) | 2004-05-07 | 2017-01-17 | W.L. Gore & Associates, Inc. | Catching mechanisms for tubular septal occluder |
US9332993B2 (en) | 2004-08-05 | 2016-05-10 | Cardiokinetix, Inc. | Devices and methods for delivering an endocardial device |
US9332992B2 (en) | 2004-08-05 | 2016-05-10 | Cardiokinetix, Inc. | Method for making a laminar ventricular partitioning device |
US9259267B2 (en) | 2005-09-06 | 2016-02-16 | W.L. Gore & Associates, Inc. | Devices and methods for treating cardiac tissue |
US9198669B2 (en) | 2006-03-31 | 2015-12-01 | Spiration, Inc. | Articulable anchor |
US8870913B2 (en) | 2006-03-31 | 2014-10-28 | W.L. Gore & Associates, Inc. | Catch system with locking cap for patent foramen ovale (PFO) occluder |
US9005242B2 (en) | 2007-04-05 | 2015-04-14 | W.L. Gore & Associates, Inc. | Septal closure device with centering mechanism |
US8845711B2 (en) | 2007-10-19 | 2014-09-30 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US8840641B2 (en) | 2009-01-08 | 2014-09-23 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US8690911B2 (en) | 2009-01-08 | 2014-04-08 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US9572584B2 (en) | 2009-01-08 | 2017-02-21 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US8974445B2 (en) | 2009-01-09 | 2015-03-10 | Recor Medical, Inc. | Methods and apparatus for treatment of cardiac valve insufficiency |
US9351716B2 (en) | 2009-06-17 | 2016-05-31 | Coherex Medical, Inc. | Medical device and delivery system for modification of left atrial appendage and methods thereof |
JP7082987B2 (en) | 2017-04-05 | 2022-06-09 | ナショナル・ユニバーシティ・オブ・アイルランド・ガルウェイ | Implantable medical device |
Also Published As
Publication number | Publication date |
---|---|
CN1342056A (en) | 2002-03-27 |
US6152144A (en) | 2000-11-28 |
ATE512630T1 (en) | 2011-07-15 |
CA2349667A1 (en) | 2000-05-18 |
AU771096B2 (en) | 2004-03-11 |
HK1045452B (en) | 2009-03-27 |
CN100394895C (en) | 2008-06-18 |
HK1045452A1 (en) | 2002-11-29 |
AU1715300A (en) | 2000-05-29 |
EP1135068A4 (en) | 2006-07-12 |
WO2000027292A1 (en) | 2000-05-18 |
ES2367414T3 (en) | 2011-11-03 |
EP1135068A1 (en) | 2001-09-26 |
CA2349667C (en) | 2006-05-16 |
EP1135068B1 (en) | 2011-06-15 |
JP2003529384A (en) | 2003-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9168043B2 (en) | Method for left atrial appendage occlusion | |
US6994092B2 (en) | Device for containing embolic material in the LAA having a plurality of tissue retention structures | |
EP1135068B1 (en) | Device for left atrial appendage occlusion | |
EP1605865B1 (en) | Stent with thin film composite laminate | |
US20180206830A1 (en) | Method of implanting an adjustable occlusion device | |
US20050038470A1 (en) | System and method for delivering a left atrial appendage containment device | |
MXPA01004564A (en) | Method and device for left atrial appendage occlusion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 99815453.9 Country of ref document: CN |
|
ENP | Entry into the national phase |
Ref document number: 2000 17153 Country of ref document: AU Kind code of ref document: A |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ CZ DE DE DK DK DM EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: C2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ CZ DE DE DK DK DM EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
COP | Corrected version of pamphlet |
Free format text: PAGES 1/20-20/20, DRAWINGS, REPLACED BY NEW PAGES 1/20-20/20; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2001/004564 Country of ref document: MX |
|
ENP | Entry into the national phase |
Ref document number: 2349667 Country of ref document: CA Ref document number: 2349667 Country of ref document: CA Kind code of ref document: A Ref document number: 2000 580529 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 17153/00 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999960236 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1999960236 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 17153/00 Country of ref document: AU |